Title,URL,Time Published,Authors,Summary,Banner Image,Source,Category Within Source,Source Domain,Topics,Overall Sentiment Score,Overall Sentiment Label,Ticker Sentiment
"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35491796/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv,20231030T142146,['Globe Newswire'],"NEW YORK, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.045664,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.692465', 'ticker_sentiment_score': '0.053559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.052379', 'ticker_sentiment_label': 'Neutral'}]"
Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks,https://www.fool.com/investing/2023/10/30/nearly-70-of-warren-buffetts-326-billion-portfolio/,20231030T095000,['Keith Speights'],The Oracle of Omaha likes big stocks.,https://g.foolcdn.com/editorial/images/751796/buffett17-tmf.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.2105,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.061548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.324324', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVX', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.085841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.056933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.085853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.133286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.028381', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.167322', 'ticker_sentiment_score': '0.156397', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Smoke Evacuation Systems Market Revenue to Cross USD 298.8 million by 2031, Garnering 6.6% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/10/g35484877/smoke-evacuation-systems-market-revenue-to-cross-usd-298-8-million-by-2031-garnering-6-6-cagr-tmr-,20231030T093000,['Globe Newswire'],"Wilmington, Delaware, United States, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The smoke evacuation systems market was estimated to have acquired US$ 158.5 million in 2021. It is anticipated to register a 6.6% CAGR from 2022 to 2031, and by 2031, the market is likely ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.210611,Somewhat-Bullish,"[{'ticker': 'UTMD', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.15617', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CNMD', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.124109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ECL', 'relevance_score': '0.03798', 'ticker_sentiment_score': '-0.099276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.051531', 'ticker_sentiment_label': 'Neutral'}]"
Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks,https://www.fool.com/investing/2023/10/30/warren-buffett-secret-portfolio-buy-3-cheap-stocks/,20231030T090600,['Sean Williams'],The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F752005%2Fbuffett11-tmf.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.196573,Somewhat-Bullish,"[{'ticker': 'SPGI', 'relevance_score': '0.031322', 'ticker_sentiment_score': '0.09646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.216583', 'ticker_sentiment_score': '0.136145', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.031322', 'ticker_sentiment_score': '0.063081', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.093775', 'ticker_sentiment_score': '0.108779', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.155652', 'ticker_sentiment_score': '0.146779', 'ticker_sentiment_label': 'Neutral'}]"
KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-ongoing-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301970622.html,20231030T004500,[],KENVUE ONGOING DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.150018,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.600121', 'ticker_sentiment_score': '0.021496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.093005', 'ticker_sentiment_label': 'Neutral'}]"
"Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue Inc.",https://www.prnewswire.com/news-releases/kessler-topaz-meltzer--check-llp-announces-investor-securities-fraud-class-action-lawsuit-filed-against-kenvue-inc-301970546.html,20231029T142000,"['LLP', 'Kessler Topaz Meltzer & Check']","Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Kenvue ... PR ...",https://mma.prnewswire.com/media/277422/ktmc_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.104448,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.63188', 'ticker_sentiment_score': '-0.014767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.059785', 'ticker_sentiment_score': '0.135003', 'ticker_sentiment_label': 'Neutral'}]"
"Dermatitis is not just skin-deep: A common skin condition, it can be irritating and painful",https://www.financialexpress.com/healthcare/dermatitis-is-not-just-skin-deep-a-common-skin-condition-it-can-be-irritating-and-painful/3289895/,20231028T221500,['Vaishali Dar'],"What do Jessica Simpson, Kerry Washington, Elle Fanning, Tia Mowry, Kristen Bell and Seonghwa have in common? Well, apart from being well-known celebrities, they have all battled with skin conditions and have either announced or discussed them on social media.",https://www.financialexpress.com/wp-content/uploads/2023/10/rash.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.126965,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.058159', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.024852', 'ticker_sentiment_score': '0.012074', 'ticker_sentiment_label': 'Neutral'}]"
"Meta's Plans, Cyberattacks, and the EV Race",https://www.fool.com/investing/2023/10/28/metas-plans-cyberattacks-and-the-ev-race/,20231028T134500,['Motley Fool Staff'],And we've got a look at two stocks worth watching: Chevron and Burford Capital.,https://g.foolcdn.com/editorial/images/750412/mfm_2023106.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.098033,Neutral,"[{'ticker': 'ASR', 'relevance_score': '0.012831', 'ticker_sentiment_score': '0.022594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PYPL', 'relevance_score': '0.025658', 'ticker_sentiment_score': '0.032892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BC', 'relevance_score': '0.006416', 'ticker_sentiment_score': '-0.021367', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.019245', 'ticker_sentiment_score': '0.016558', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.038479', 'ticker_sentiment_score': '0.010865', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.041714', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRWD', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.16004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.109807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.080732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.012831', 'ticker_sentiment_score': '-0.089339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.012831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JCI', 'relevance_score': '0.006416', 'ticker_sentiment_score': '-0.021367', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.064087', 'ticker_sentiment_score': '0.053087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPB', 'relevance_score': '0.006416', 'ticker_sentiment_score': '-0.021367', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.16004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.080732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.019245', 'ticker_sentiment_score': '0.094921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZS', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.16004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CZR', 'relevance_score': '0.012831', 'ticker_sentiment_score': '-0.022509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLY', 'relevance_score': '0.006416', 'ticker_sentiment_score': '0.16004', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime",https://www.fool.com/investing/2023/10/28/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/,20231028T090300,['Matthew DiLallo'],These elite companies make exceptional foundational investments for any portfolio.,https://media.ycharts.com/charts/3c06d1f2f316d1582497ce1299ae622f.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.444475,Bullish,"[{'ticker': 'CRBO', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.240929', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.318211', 'ticker_sentiment_score': '0.470206', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NEE', 'relevance_score': '0.267413', 'ticker_sentiment_score': '0.485279', 'ticker_sentiment_label': 'Bullish'}]"
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now,https://www.fool.com/investing/2023/10/28/have-500-dollars-2-absurdly-cheap-stocks-to-buy/,20231028T090000,['Adria Cimino'],A few hundred dollars invested today could go a long way over time.,https://media.ycharts.com/charts/3b81ea44fb824b020c874af7387f846c.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.999816'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.364536,Bullish,"[{'ticker': 'KO', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.370779', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.123844', 'ticker_sentiment_score': '0.124049', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson produces documents in DoJ civil investigation of eye products,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-produces-documents-doj-civil-investigation-eye-products-2023-10-27/,20231027T212300,['Reuters'],"The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights Oct 27 ( Reuters ) - Johnson & Johnson ( JNJ.N ) has begun providing documents and information in response to a civil ...",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/S2PVLT5FPJKPZGMG67RYMKUCTE.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.228432,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.760593', 'ticker_sentiment_score': '0.420122', 'ticker_sentiment_label': 'Bullish'}]"
"Kessler Topaz Meltzer & Check, LLP ANNOUNCES A SECURITIES FRAUD CLASS ACTION FILED AGAINST KENVUE INC. - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35474631/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-filed-against-kenvue-inc,20231027T210159,['Globe Newswire'],"RADNOR, Pa., Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.096899,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.526003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.129961', 'ticker_sentiment_label': 'Neutral'}]"
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/health-care/23/10/35469218/is-ozempic-killing-liposuction-a-stock-that-could-get-hit-hard-from-new-weight-loss-drugs,20231027T191555,['Aaron Bry'],"Ozempic, Novo Nordisk's NVO diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such as liposuction and bariatric surgeries. Some companies are already seeing the impact of widespread Ozempic use.",https://cdn.benzinga.com/files/images/story/2023/10/27/weightloss.shutterstock_2270507665.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.062611,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.316846', 'ticker_sentiment_score': '-0.116065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.316846', 'ticker_sentiment_score': '-0.073174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.316846', 'ticker_sentiment_score': '-0.31328', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35470371/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,20231027T174247,['Globe Newswire'],"NEW YORK, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.021762,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.691995', 'ticker_sentiment_score': '0.011422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.021477', 'ticker_sentiment_label': 'Neutral'}]"
"AbbVie  ( ABBV )  Q3 Earnings Beat, Shares Down Despite Raised View",https://www.zacks.com/stock/news/2173886/abbvie-abbv-q3-earnings-beat-shares-down-despite-raised-view,20231027T145100,['Zacks Equity Research'],"AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.",https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.993856'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.121556,Neutral,"[{'ticker': 'CHRS', 'relevance_score': '0.037213', 'ticker_sentiment_score': '-0.05635', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.291038', 'ticker_sentiment_score': '0.312919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.148045', 'ticker_sentiment_score': '-0.029829', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GMAB', 'relevance_score': '0.037213', 'ticker_sentiment_score': '0.285488', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.074345', 'ticker_sentiment_score': '0.131252', 'ticker_sentiment_label': 'Neutral'}]"
"FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie - Eli Lilly  ( NYSE:LLY ) ",https://www.benzinga.com/general/biotech/23/10/35465199/fda-gives-nod-to-eli-lillys-first-treatment-for-type-of-inflammatory-bowel-disease-to-compete-wit,20231027T142819,['Vandana Singh'],"The FDA approved Eli Lilly And Co's LLY Omvoh ( mirikizumab-mrkz ) for moderately to severely active ulcerative colitis ( UC ) in adults, marking Lilly's first approved treatment for a type of inflammatory bowel disease.",https://cdn.benzinga.com/files/images/story/2023/10/27/lly.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.259077,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.642555', 'ticker_sentiment_score': '0.486525', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.447515', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.447515', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.2872', 'ticker_sentiment_score': '0.447515', 'ticker_sentiment_label': 'Bullish'}]"
Sanofi loses $21 bn in market value after dropping 2025 profit target,https://www.business-standard.com/companies/news/sanofi-loses-21-bn-in-market-value-after-dropping-2025-profit-target-123102701074_1.html,20231027T141823,['Reuters'],"Sanofi stock plunged on Friday, wiping 20 billion euros ( $21 billion ) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer healthcare business to focus on its core innovative drugs business.","https://bsmedia.business-standard.com/_media/bs/img/article/2023-01/30/full/1675098773-8562.jpg?im=FitAndFill=(826,465)",Business Standard,GoogleRSS,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.998287'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.129293,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.001999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.001999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.001999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049526', 'ticker_sentiment_score': '0.001999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.423843', 'ticker_sentiment_score': '0.137287', 'ticker_sentiment_label': 'Neutral'}]"
Is iShares Core High Dividend ETF  ( HDV )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2173449/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now,20231027T102007,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.273753,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.056808', 'ticker_sentiment_score': '0.048934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.147499', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.060706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.060706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.113329', 'ticker_sentiment_score': '0.060706', 'ticker_sentiment_label': 'Neutral'}]"
Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of 14.94% | Infinium Global Research,https://www.prnewswire.com/news-releases/global-medical-robotics-market-is-forecast-to-reach-a-value-of-usd-28-77-billion-by-2030-with-a-growing-cagr-of-14-94--infinium-global-research-301970015.html,20231027T100300,['Infinium Global Research'],Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion By 2030 with a Growing CAGR of ... PR ...,https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.305753,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EKSO', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMCL', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'III', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.164249', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.066226', 'ticker_sentiment_label': 'Neutral'}]"
"Sanofi shares plunge after 2025 target dropped, consumer unit marked for spin-off",https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-considering-consumer-unit-listing-late-next-year-2023-10-27/,20231027T080000,['Ludwig Burger'],"Sanofi shares plunge after 2025 target dropped, consumer unit marked for ...",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WRF25P62ZFJITPPAPS2ZD2I67A.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.99237'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.163962,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.056943', 'ticker_sentiment_score': '0.002002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.056943', 'ticker_sentiment_score': '0.002002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.056943', 'ticker_sentiment_score': '0.002002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.056943', 'ticker_sentiment_score': '0.002002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.567965', 'ticker_sentiment_score': '0.318076', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Sanofi takes page from rivals' separation playbook,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-takes-page-rivals-separation-playbook-2023-10-27/,20231027T073600,['Reuters'],"FILE PHTOO: The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/6TKBWAWBEBJ6HJV4QVUL3YP744.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",-0.058979,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.100729', 'ticker_sentiment_score': '-0.018451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.100729', 'ticker_sentiment_score': '-0.018451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.100729', 'ticker_sentiment_score': '-0.018451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.100729', 'ticker_sentiment_score': '-0.018451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.295867', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Analysis: Healthcare companies counter investor worries over Wegovy effect,https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/,20231027T050020,"['Manas Mishra', 'David Gaffen']","A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",https://s3.amazonaws.com/arc-authors/reuters/64c98ae2-82dc-4c80-b81f-dc010b8de5de.png,Reuters,Business,www.reuters.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}]",0.040704,Neutral,"[{'ticker': 'RMD', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.003987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.018908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.052759', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.049221', 'ticker_sentiment_score': '0.016001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.098255', 'ticker_sentiment_score': '0.124991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049221', 'ticker_sentiment_score': '-0.129072', 'ticker_sentiment_label': 'Neutral'}]"
"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301969520.html,20231027T030000,[],"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.065474,Neutral,"[{'ticker': 'SNN', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVY', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZLGF', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPBY', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORGO', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNVVF', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.082671', 'ticker_sentiment_label': 'Neutral'}]"
Kenvue  ( KVUE )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/26/kenvue-kvue-q3-2023-earnings-call-transcript/,20231026T183024,['Motley Fool Transcribing'],"KVUE earnings call for the period ending September 30, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.331389,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.039795', 'ticker_sentiment_score': '0.16753', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.004976', 'ticker_sentiment_score': '0.182945', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.004976', 'ticker_sentiment_score': '0.182945', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.004976', 'ticker_sentiment_score': '0.182945', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ICNB', 'relevance_score': '0.029851', 'ticker_sentiment_score': '0.204375', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.009953', 'ticker_sentiment_score': '0.185623', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:UYU', 'relevance_score': '0.004976', 'ticker_sentiment_score': '-0.126599', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:RUB', 'relevance_score': '0.004976', 'ticker_sentiment_score': '-0.126599', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.004976', 'ticker_sentiment_score': '0.032226', 'ticker_sentiment_label': 'Neutral'}]"
JNJ: 3 Pharma Stocks on the Rise - Buy Now,https://stocknews.com/news/jnj-azn-sny-3-pharma-stocks-on-the-rise-buy-now/,20231026T154843,['StockNews.com Staff'],"The pharmaceutical industry is set to grow in the coming years thanks to an aging population, chronic diseases, and new technologies. In this article, we'll look at the fundamentals of three pharma stocks, Sanofi ( SNY ) , Johnson & Johnson ( JNJ ) and AstraZeneca PLC ( AZN ) , which can boost ...",https://stocknews.com/wp-content/uploads/2022/03/shutterstock_745024336-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.999701'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.303463,Somewhat-Bullish,"[{'ticker': 'FWBI', 'relevance_score': '0.034136', 'ticker_sentiment_score': '0.125736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.202648', 'ticker_sentiment_score': '0.207864', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.068209', 'ticker_sentiment_score': '0.068173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSOI', 'relevance_score': '0.034136', 'ticker_sentiment_score': '0.08627', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.202648', 'ticker_sentiment_score': '0.136799', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.235496', 'ticker_sentiment_score': '0.116023', 'ticker_sentiment_label': 'Neutral'}]"
"Scleroderma Market Outlook 2023-2027: Expected Market Size, Growth Drivers, And Key Trends As Per The Business Research Company's Scleroderma Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444019/scleroderma-market-outlook-2023-2027-expected-market-size-growth-drivers-and-key-trends-as-per-the,20231026T153000,['Globe Newswire'],"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Scleroderma Global Market Report 2023, the global scleroderma market is on an upward trajectory, with expectations of reaching $2.15 billion in 2023, signifying a compound annual growth rate ( CAGR ) of 7.5%.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.251023,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.071658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.071658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.071658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.071658', 'ticker_sentiment_label': 'Neutral'}]"
"Fatty Liver Treatment Market Is Set To Grow At A CAGR Of 6%, Driven By Rise In Alcohol Consumption As Per The Business Research Company's Fatty Liver Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35444012/fatty-liver-treatment-market-is-set-to-grow-at-a-cagr-of-6-driven-by-rise-in-alcohol-consumption-a,20231026T153000,['Globe Newswire'],"LONDON, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Fatty Liver Treatment Global Market Report 2023, the global fatty liver treatment market is gearing up for substantial growth, expected to rise from $20.83 billion in 2022 to $22.17 billion in 2023, with a ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.045999,Neutral,"[{'ticker': 'AKRO', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.060046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KNBWF', 'relevance_score': '0.05749', 'ticker_sentiment_score': '-0.09449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.06602', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.06602', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.06602', 'ticker_sentiment_label': 'Neutral'}]"
"Build Relationships that Drive Revenue at Transform 2023, Hosted by Showpad",https://www.benzinga.com/pressreleases/23/10/g35441300/build-relationships-that-drive-revenue-at-transform-2023-hosted-by-showpad,20231026T141324,['Globe Newswire'],"Discover the trends shaping the industry and hear first-hand from sales enablement experts at Stanley Black & Decker, Kaiser Permanente, Regal Rexnord, and LastPass, on how to unlock sales potential at Showpad's Transform 2023",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.214378'}]",0.28752,Somewhat-Bullish,"[{'ticker': 'GIC', 'relevance_score': '0.043818', 'ticker_sentiment_score': '0.077902', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RRX', 'relevance_score': '0.087503', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCEP', 'relevance_score': '0.043818', 'ticker_sentiment_score': '0.067432', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.043818', 'ticker_sentiment_score': '0.067432', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.043818', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043818', 'ticker_sentiment_score': '0.067432', 'ticker_sentiment_label': 'Neutral'}]"
"Kenvue tempers annual profit view on soft demand for cold, flu medicines",https://www.reuters.com/business/healthcare-pharmaceuticals/kenvue-reports-higher-q3-revenue-self-care-products-strength-2023-10-26/,20231026T141100,['Bhanvi Satija'],"[1/2] The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange ( NYSE ) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",https://s3.amazonaws.com/arc-authors/reuters/24e53264-190b-4097-835a-edeca236a9f4.png,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.858979'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.05027,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.493128', 'ticker_sentiment_score': '0.067399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.105604', 'ticker_sentiment_score': '0.129029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.105604', 'ticker_sentiment_score': '-0.045208', 'ticker_sentiment_label': 'Neutral'}]"
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income,https://www.fool.com/investing/2023/10/26/2-magnifient-dividend-stocks-that-could-deliver-a/,20231026T114500,['George Budwell'],These two healthcare stocks are proven passive income vehicles.,https://media.ycharts.com/charts/5430b19acc87c6b192178bfb89679292.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.313968,Somewhat-Bullish,"[{'ticker': 'PFE', 'relevance_score': '0.38489', 'ticker_sentiment_score': '0.328703', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.090457', 'ticker_sentiment_label': 'Neutral'}]"
3 Pharma Stocks That Are Screaming Buys in October,https://www.fool.com/investing/2023/10/26/3-pharma-stocks-that-are-screaming-buys-in-october/,20231026T113000,['Jim Halley'],Each company delivers an above-average dividend and revenue growth.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.109768,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.076115', 'ticker_sentiment_score': '0.002043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.076115', 'ticker_sentiment_score': '-0.044986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.151539', 'ticker_sentiment_score': '0.035847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.188781', 'ticker_sentiment_score': '0.100446', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( NYSE:JNJ )  Upgraded to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/10/26/johnson-johnson-nysejnj-upgraded-to-strong-buy-at-stocknews-com.html,20231026T072246,['Defense World Staff'],Johnson & Johnson ( NYSE:JNJ ) Upgraded to Strong-Buy at ... Defense World ...,https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.340403,Somewhat-Bullish,"[{'ticker': 'MS', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.07503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.806749', 'ticker_sentiment_score': '0.538381', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RBCPF', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.07503', 'ticker_sentiment_label': 'Neutral'}]"
InnovationRx: Ransomware Attacks On U.S. Health Systems Have Cost The Economy Nearly $80 Billion,https://www.forbes.com/sites/alexknapp/2023/10/25/innovationrx-ransomware-attacks-on-us-health-systems-have-cost-the-economy-nearly-8-billion/,20231026T004247,['Alex Knapp'],"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.",https://imageio.forbes.com/specials-images/imageserve/6539b5a9b1998d930ede083e/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.031463,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.106541', 'ticker_sentiment_score': '-0.055926', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTXR', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.107688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.05339', 'ticker_sentiment_score': '-0.114687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.059975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.05339', 'ticker_sentiment_score': '-0.292031', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CNC', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.120688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TENK', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.107688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INSM', 'relevance_score': '0.05339', 'ticker_sentiment_score': '-0.068726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BFLY', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.059975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:PAY', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.107688', 'ticker_sentiment_label': 'Neutral'}]"
Icertis Named a Leader in 2023 Gartner® Magic Quadrant™ for Contract Life Cycle Management,https://www.prnewswire.com/news-releases/icertis-named-a-leader-in-2023-gartner-magic-quadrant-for-contract-life-cycle-management-301966992.html,20231025T163000,['Icertis'],"BELLEVUE, Wash., Oct. 25, 2023 /PRNewswire/ -- Icertis announced today that it has been named a Leader in the 2023 Gartner Magic Quadrant for Contract Life Cycle Management ( CLM ) 1.",https://mma.prnewswire.com/media/371539/Icertis_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.336683,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.09439', 'ticker_sentiment_score': '0.159633', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.095863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.095863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBY', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.095863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IT', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.053193', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.095863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICNB', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.046982', 'ticker_sentiment_label': 'Neutral'}]"
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35418916/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,20231025T152300,['Globe Newswire'],"LOS ANGELES, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.021733,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.612343', 'ticker_sentiment_score': '0.039842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.086023', 'ticker_sentiment_label': 'Neutral'}]"
Transdermal Drug Delivery System Market to Hit 4.3% CAGR with Transdermal Gels Segment Driving Growth During 2022-2030 | The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35417362/transdermal-drug-delivery-system-market-to-hit-4-3-cagr-with-transdermal-gels-segment-driving-grow,20231025T144015,['Globe Newswire'],"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient's skin.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.203812,Somewhat-Bullish,"[{'ticker': 'LYPHF', 'relevance_score': '0.229149', 'ticker_sentiment_score': '0.170559', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UCBJF', 'relevance_score': '0.025817', 'ticker_sentiment_score': '0.061488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.025817', 'ticker_sentiment_score': '0.061488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HTSUF', 'relevance_score': '0.025817', 'ticker_sentiment_score': '0.061488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.025817', 'ticker_sentiment_score': '0.061488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.025817', 'ticker_sentiment_score': '0.061488', 'ticker_sentiment_label': 'Neutral'}]"
"Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC",https://www.zacks.com/stock/news/2171776/drug-biotech-stocks-q3-earnings-due-on-oct-26-bmy-mrk-bpmc,20231025T141500,['Ahan Chakraborty'],"Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.",https://staticx-tuner.zacks.com/images/articles/main/7e/42272.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.160128,Somewhat-Bullish,"[{'ticker': 'BMY', 'relevance_score': '0.201523', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BPMC', 'relevance_score': '0.344987', 'ticker_sentiment_score': '0.138282', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.131226', 'ticker_sentiment_label': 'Neutral'}]"
"Surgical Robots Market to Hit 14.8% CAGR, Globally Driven by Increase in Surgical Procedures During 2022-2028 | The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35416590/surgical-robots-market-to-hit-14-8-cagr-globally-driven-by-increase-in-surgical-procedures-during-,20231025T140919,['Globe Newswire'],"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- Surgical Robots are robotic systems operated by surgeons consisting of miniaturized surgical instruments mounted on robotic arms. These are controlled by the surgeons on a computer console that offers HD and a magnified 3-D view of the surgical ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.243026,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.097864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.097864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSMXF', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.152758', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DSSMY', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.097864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSII', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.114334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.097864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RNSHF', 'relevance_score': '0.034185', 'ticker_sentiment_score': '0.097864', 'ticker_sentiment_label': 'Neutral'}]"
Powerful senators fire off letter decrying 'abusive' tactics in Corizon bankruptcy,https://www.businessinsider.com/senator-warren-oversight-letter-on-corizon-tehum-yescare-bankruptcy-deal-2023-10,20231025T120000,"['Dakin Campbell', 'Nicole Einbinder']",Senators press for answers from executives of Corizon successor companies - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.208222,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.029113', 'ticker_sentiment_score': '-0.073979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.029113', 'ticker_sentiment_score': '-0.196194', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Self-Diagnostic Medical Devices Market Size Worth $39.88 Billion, Globally, by 2030- Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35410523/self-diagnostic-medical-devices-market-size-worth-39-88-billion-globally-by-2030-exclusive-report-,20231025T093022,['Globe Newswire'],"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on ""Self-Diagnostic Medical Devices Market covers analysis By Product Type ( Wearable Devices, Implantable Devices, Handheld/Portable Devices, Stationary Devices, and Others ) , Component ( Software, Devices, ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.00722,Neutral,"[{'ticker': 'WLDS', 'relevance_score': '0.040553', 'ticker_sentiment_score': '-0.019693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMRNF', 'relevance_score': '0.040553', 'ticker_sentiment_score': '0.095195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040553', 'ticker_sentiment_score': '0.095195', 'ticker_sentiment_label': 'Neutral'}]"
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?,https://www.fool.com/investing/2023/10/25/2-exceptional-dividend-stocks-near-52-week-lows-ar/,20231025T091900,['Cory Renauer'],Attractive valuation metrics don't always tell the whole story.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751883%2Fconfident-investor-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.140275,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.139039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BTI', 'relevance_score': '0.242285', 'ticker_sentiment_score': '-0.056487', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.122581', 'ticker_sentiment_score': '0.240911', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"The Global AI In Healthcare Diagnosis Market Set For Explosive Growth, Projected To Reach $71.24 Billion By 2027 As Per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023",https://www.benzinga.com/pressreleases/23/10/g35397852/the-global-ai-in-healthcare-diagnosis-market-set-for-explosive-growth-projected-to-reach-71-24-bil,20231024T153500,['Globe Newswire'],"LONDON, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Artificial Intelligence In Healthcare Diagnosis Global Market Report 2023, the global Artificial Intelligence ( AI ) in healthcare diagnosis market is poised for a remarkable surge, with a projected growth from ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.402041,Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INTC', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.240059', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
JNJ: Should You Invest in Johnson & Johnson  ( JNJ )  Following Q3 Results,https://stocknews.com/news/jnj-nvs-abbv-nvo-should-you-invest-in-johnson-johnson-jnj-following-q3/,20231024T144418,['StockNews.com Staff'],JNJ: Should You Invest in Johnson & Johnson ( JNJ ) Following Q3 ... ...,https://stocknews.com/wp-content/uploads/2020/09/jnj-mmm-dg.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.999975'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.217713,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.083687', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.083687', 'ticker_sentiment_score': '0.067449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.083687', 'ticker_sentiment_score': '0.067449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.083687', 'ticker_sentiment_score': '0.067449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.628234', 'ticker_sentiment_score': '0.331411', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 High-Yielding Dividend Stocks Near Their 52-Week Lows,https://www.fool.com/investing/2023/10/24/3-high-yielding-dividend-stocks-near-their-52-week/,20231024T114500,['David Jagielski'],"Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.118579,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.321673', 'ticker_sentiment_score': '0.210712', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.321673', 'ticker_sentiment_score': '0.01945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.321673', 'ticker_sentiment_score': '0.209912', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.055109', 'ticker_sentiment_score': '0.011995', 'ticker_sentiment_label': 'Neutral'}]"
"The Best Stocks to Invest $5,000 In Right Now",https://www.fool.com/investing/2023/10/24/the-best-stocks-to-invest-5000-in-right-now/,20231024T093000,['Adria Cimino'],"Today, the following three healthcare players look like fantastic bargains.",https://media.ycharts.com/charts/9580ab8fffe7217f39b1987355fdd495.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.323116,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.102668', 'ticker_sentiment_score': '0.183773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.102668', 'ticker_sentiment_score': '0.214111', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.203643', 'ticker_sentiment_score': '0.121416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.102668', 'ticker_sentiment_score': '0.175114', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking,https://www.fool.com/investing/2023/10/24/2-cheap-dow-dividend-kings-are-ripe-for-picking/,20231024T092100,['Sean Williams'],These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751877%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.228638,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.004947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TWOHD', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.270018', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.333757', 'ticker_sentiment_score': '0.353798', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.200047', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.076358', 'ticker_sentiment_score': '-0.041088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.298567', 'ticker_sentiment_score': '0.116827', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.201042', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.004947', 'ticker_sentiment_label': 'Neutral'}]"
Idorsia announces financial results for the first nine months of 2023 - adapting the company to create sustainable value,https://www.globenewswire.com/news-release/2023/10/24/2765251/0/en/Idorsia-announces-financial-results-for-the-first-nine-months-of-2023-adapting-the-company-to-create-sustainable-value.html,20231024T050000,['Idorsia Pharmaceuticals Ltd'],Ad hoc announcement pursuant to Art. 53 LR ...,https://ml-eu.globenewswire.com/Resource/Download/2b5c6373-4972-498a-b81c-ac336e21be66,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.147568,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.023146', 'ticker_sentiment_score': '0.051334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SOLTF', 'relevance_score': '0.261361', 'ticker_sentiment_score': '0.044993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IDRSF', 'relevance_score': '0.283148', 'ticker_sentiment_score': '0.156458', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.011574', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.011574', 'ticker_sentiment_score': '0.105523', 'ticker_sentiment_label': 'Neutral'}]"
Phase 3 MARIPOSA-2 Study Shows RYBREVANT®  ( amivantamab-vmjw )  Plus Chemotherapy Given with or without Lazertinib Reduced Risk of Disease Progression or Death by 56 and 52 Percent Respectively in Patients with EGFR-Mutated Non-Small Cell Lung Cancer who Progressed on or after Osimertinib,https://www.prnewswire.com/news-releases/phase-3-mariposa-2-study-shows-rybrevant-amivantamab-vmjw-plus-chemotherapy-given-with-or-without-lazertinib-reduced-risk-of-disease-progression-or-death-by-56-and-52-percent-respectively-in-patients-with-egfr-mutated-non-small-301964621.html,20231023T144400,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Phase 3 MARIPOSA-2 Study Shows RYBREVANT® ( amivantamab-vmjw ) Plus Chemotherapy Given with or without ... PR ...,https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.016917,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.058', 'ticker_sentiment_score': '0.020062', 'ticker_sentiment_label': 'Neutral'}]"
Charles River  ( CRL )  Offers Access to Preclinical Cancer Research,https://www.zacks.com/stock/news/2170290/charles-river-crl-offers-access-to-preclinical-cancer-research,20231023T141000,['Zacks Equity Research'],Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.,https://staticx-tuner.zacks.com/images/articles/main/ca/2974.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.160598,Somewhat-Bullish,"[{'ticker': 'CRL', 'relevance_score': '0.115232', 'ticker_sentiment_score': '-0.165166', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.121222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.172097', 'ticker_sentiment_score': '0.118379', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2170161/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,20231023T130010,['Zacks Equity Research'],"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default96.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.219855,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.133307', 'ticker_sentiment_label': 'Neutral'}]"
New Phase 3 TREMFYA®  ( guselkumab )  Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response Rate and Early Symptom Improvement,https://www.prnewswire.com/news-releases/new-phase-3-tremfya-guselkumab-results-in-ulcerative-colitis-show-a-77-percent-overall-clinical-response-rate-and-early-symptom-improvement-301963553.html,20231023T113100,['Janssen Pharmaceutical Companies of Johnson & Johnson'],New Phase 3 TREMFYA® ( guselkumab ) Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response ... PR ...,https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.043506,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.215149', 'ticker_sentiment_score': '0.01562', 'ticker_sentiment_label': 'Neutral'}]"
The 3 Safest Warren Buffett Stocks to Buy and Hold for the Next 20 Years,https://www.fool.com/investing/2023/10/23/the-3-safest-warren-buffett-stocks-to-buy-and-hold/,20231023T105000,['Keith Speights'],These stocks are less risky than most.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999696'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.220733,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.105469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.09359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.105469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.105469', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSBHF', 'relevance_score': '0.545493', 'ticker_sentiment_score': '0.404096', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MKL', 'relevance_score': '0.439243', 'ticker_sentiment_score': '0.310775', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
AbbVie  ( ABBV )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170056/abbvie-abbv-to-report-q3-earnings-whats-in-the-cards,20231023T083200,['Zacks Equity Research'],AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.,https://staticx-tuner.zacks.com/images/articles/main/36/1919.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.202745,Somewhat-Bullish,"[{'ticker': 'SSNLF', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.029734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.412523', 'ticker_sentiment_score': '0.324419', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.2138', 'ticker_sentiment_score': '0.05686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.2138', 'ticker_sentiment_score': '-0.004984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043264', 'ticker_sentiment_score': '0.115711', 'ticker_sentiment_label': 'Neutral'}]"
"Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now",https://www.fool.com/investing/2023/10/22/down-double-digits-these-buffett-stocks-are-buys/,20231022T105000,['Adria Cimino'],These players could deliver top returns over the long haul.,https://media.ycharts.com/charts/646704df6df1248cf3e6f53093aef562.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.394919,Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.180269', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.452384', 'ticker_sentiment_score': '0.476119', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.053271', 'ticker_sentiment_score': '0.169715', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.106305', 'ticker_sentiment_score': '0.015372', 'ticker_sentiment_label': 'Neutral'}]"
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth,https://www.fool.com/investing/2023/10/22/3-foundational-blue-chip-dow-dividend-stocks/,20231022T090300,['Daniel Foelber'],Dow stocks can provide the confidence needed to hold through periods of volatility.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749878%2Fgettyimages-600148200.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}]",0.229856,Somewhat-Bullish,"[{'ticker': 'CVX', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.210604', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.039548', 'ticker_sentiment_score': '-0.007966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.157227', 'ticker_sentiment_score': '0.098489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.039548', 'ticker_sentiment_score': '-0.007966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.039548', 'ticker_sentiment_score': '0.171857', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KVUE', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.065699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.343295', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Prednisone,https://www.prnewswire.com/news-releases/final-multivariate-analysis-from-the-phase-3-magnitude-study-shows-trend-toward-improvement-in-overall-survival-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-brca-alterations-treated-with-niraparib-and-abir-301963785.html,20231022T063000,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival ... PR ...,https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.055604,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.085411', 'ticker_sentiment_score': '0.023147', 'ticker_sentiment_label': 'Neutral'}]"
New Data from Phase 3 PAPILLON Study Show RYBREVANT®  ( amivantamab-vmjw )  Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer,https://www.prnewswire.com/news-releases/new-data-from-phase-3-papillon-study-show-rybrevant-amivantamab-vmjw-plus-chemotherapy-resulted-in-60-percent-reduction-in-risk-of-disease-progression-or-death-in-patients-with-previously-untreated-egfr-exon-20-insertion-mutati-301963753.html,20231021T143000,['Janssen Pharmaceutical Companies of Johnson & Johnson'],New Data from Phase 3 PAPILLON Study Show RYBREVANT® ( amivantamab-vmjw ) Plus Chemotherapy Resulted in ... PR ...,https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",0.0,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.073418', 'ticker_sentiment_score': '0.020485', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JWCTF', 'relevance_score': '0.010503', 'ticker_sentiment_score': '0.057474', 'ticker_sentiment_label': 'Neutral'}]"
2 Warren Buffett Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/10/21/2-warren-buffett-dividend-stocks-to-buy-and-hold/,20231021T140700,['Prosper Junior Bakiny'],Most people have come across these companies' services.,https://media.ycharts.com/charts/5fb63464fc1d8ee2513c437bc63058a4.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.265109,Somewhat-Bullish,"[{'ticker': 'MA', 'relevance_score': '0.054857', 'ticker_sentiment_score': '0.041005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.269181', 'ticker_sentiment_score': '0.273944', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.417995', 'ticker_sentiment_score': '0.316087', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever  ( No Matter What Comes Next ) ,https://www.fool.com/investing/2023/10/21/bull-market-or-recession-2-index-funds-to-buy-now/,20231021T110700,['Trevor Jennewine'],"Through economic booms and recessions, bull markets and bear markets, these resilient index funds have consistently made money for patient investors.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999756'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}]",0.139933,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.044222', 'ticker_sentiment_score': '-0.181439', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.088309', 'ticker_sentiment_score': '-0.192141', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HCSG', 'relevance_score': '0.044222', 'ticker_sentiment_score': '0.029705', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.044222', 'ticker_sentiment_score': '-0.181439', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.044222', 'ticker_sentiment_score': '-0.181439', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
These 2 Dow Stocks Moved Markets This Week,https://www.fool.com/investing/2023/10/21/these-2-dow-stocks-moved-markets-this-week/,20231021T102700,['Dan Caplinger'],Bulls and bears alike looked closely at these two companies.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.196733,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.238385', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TRMNF', 'relevance_score': '0.057628', 'ticker_sentiment_score': '0.110052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.057628', 'ticker_sentiment_score': '-0.052162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.171688', 'ticker_sentiment_score': '0.075518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.436947', 'ticker_sentiment_score': '0.298936', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?,https://www.fool.com/investing/2023/10/21/intuitive-surgicals-revenue-dipped-is-it-time-to-s/,20231021T092700,['Cory Renauer'],"A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.",https://media.ycharts.com/charts/09f0b390f8557b76ff486827a070b862.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.15853,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.274628', 'ticker_sentiment_score': '0.082722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.326643', 'ticker_sentiment_score': '0.297294', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.027716', 'ticker_sentiment_label': 'Neutral'}]"
Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with BALVERSA®  ( erdafitinib )  Versus Chemotherapy,https://www.prnewswire.com/news-releases/results-from-phase-2-thor-2-study-show-improved-rates-of-recurrence-free-survival-in-patients-with-high-risk-non-muscle-invasive-bladder-cancer-with-select-fibroblast-growth-factor-receptor-alterations-treated-with-balversa-erda-301963725.html,20231021T065800,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Results from Phase 2 THOR-2 Study Show Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non ... PR ...,https://mma.prnewswire.com/media/622202/Janssen_Biotech_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.074457,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.099418', 'ticker_sentiment_score': '0.010968', 'ticker_sentiment_label': 'Neutral'}]"
Stocks Struggle As Yields Soar; Tesla Tumbles: Weekly Review,https://www.investors.com/news/stock-market-struggles-as-treasury-yields-soar-tesla-nvidia-among-notable-losers/,20231020T154900,"['IBD STAFF', ""Investor's Business Daily""]","Stock Market Struggles As Treasury Yields Soar. Tesla, Nvidia ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/02/Stock-UpDownArrows-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",-0.154552,Somewhat-Bearish,"[{'ticker': 'ENPH', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.304019', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UAL', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.263305', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'VMW', 'relevance_score': '0.088799', 'ticker_sentiment_score': '-0.101013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.09585', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEX', 'relevance_score': '0.11087', 'ticker_sentiment_score': '-0.277675', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.064247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.163964', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SKXJF', 'relevance_score': '0.022243', 'ticker_sentiment_score': '-0.342954', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'DSKYF', 'relevance_score': '0.022243', 'ticker_sentiment_score': '-0.342954', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'STT', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.079928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.064247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.132855', 'ticker_sentiment_score': '-0.15922', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UNP', 'relevance_score': '0.06666', 'ticker_sentiment_score': '-0.28162', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LRCX', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.048687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.088799', 'ticker_sentiment_score': '0.032981', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.069336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.068991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.088799', 'ticker_sentiment_score': '-0.160615', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSM', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.048687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.304019', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LMT', 'relevance_score': '0.06666', 'ticker_sentiment_score': '-0.106722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEDG', 'relevance_score': '0.06666', 'ticker_sentiment_score': '-0.310714', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AZN', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.359384', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.219468', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PG', 'relevance_score': '0.06666', 'ticker_sentiment_score': '0.117914', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.347311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCHW', 'relevance_score': '0.06666', 'ticker_sentiment_score': '-0.070334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.263305', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Janssen Announces TREMFYA®  ( guselkumab )  Demonstrates Significant Skin Clearance in First-of-its-Kind Prospective, Large-Scale Study Dedicated to People of Color Living with Moderate to Severe Plaque Psoriasis",https://www.prnewswire.com/news-releases/janssen-announces-tremfya-guselkumab-demonstrates-significant-skin-clearance-in-first-of-its-kind-prospective-large-scale-study-dedicated-to-people-of-color-living-with-moderate-to-severe-plaque-psoriasis-301963282.html,20231020T142500,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Janssen Announces TREMFYA® ( guselkumab ) Demonstrates Significant Skin Clearance in First-of-its-Kind ... PR ...,https://mma.prnewswire.com/media/2252793/Janssen_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",0.045716,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.108222', 'ticker_sentiment_score': '0.006817', 'ticker_sentiment_label': 'Neutral'}]"
CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors,https://apnews.com/article/cvs-health-cold-medications-phenylephrine-c8953a17b8e404cfe9e4a37d76993dc4,20231020T142400,['TOM MURPHY'],"CVS pulls some cough, cold medicines containing phenylephrine off shelves The Associated Press ...",https://dims.apnews.com/dims4/default/13114a5/2147483647/strip/true/crop/6908x4601+0+2/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fbd%2F36%2F7f8d661e992d3aed5c9ebe63456c%2F7ee9b928a8a4419896e88c65af621d04,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.106867,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.445569', 'ticker_sentiment_score': '0.174389', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.117486', 'ticker_sentiment_score': '-0.078822', 'ticker_sentiment_label': 'Neutral'}]"
Medical device makers see limited hit from weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-see-limited-hit-weight-loss-drugs-2023-10-20/,20231020T141800,['Reuters'],"[1/2] Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/V6WKJ3BLKRML3BRCVWOIWT5H3M.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.011811,Neutral,"[{'ticker': 'ISRG', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.005137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.078611', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '-0.029172', 'ticker_sentiment_label': 'Neutral'}]"
First pill for dengue shows promise in human challenge trial,https://www.reuters.com/business/healthcare-pharmaceuticals/first-pill-dengue-shows-promise-human-challenge-trial-2023-10-20/,20231020T081100,['Jennifer Rigby'],"[1/2] An assistant holds a test tube with an Aedes aegypti mosquito at the CNEA ( National Atomic Energy Commission ) , in Ezeiza, in the outskirts of Buenos Aires, Argentina April 12, 2023. REUTERS/Agustin Marcarian/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/JPYRWVWGNBJDPDJJKTUFIEABKA.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.091692,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.013549', 'ticker_sentiment_label': 'Neutral'}]"
"Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens",https://www.prnewswire.com/apac/news-releases/striving-together-for-a-thriving-industry-international-biopharma-industry-week-shanghai-2023-opens-301962953.html,20231020T072900,['Shanghai Biomedical Industry Promotion Center'],"SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai ( IBIWS 2023 ) unfolded at the Zhangjiang Science Hall in Shanghai.",https://mma.prnewswire.com/media/2251946/1.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}]",0.384066,Bullish,"[{'ticker': 'GAHC', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.031713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.190474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.190474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.190474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.190474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.019364', 'ticker_sentiment_score': '0.190474', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
StockNews.com Downgrades Johnson & Johnson  ( NYSE:JNJ )  to Buy,https://www.defenseworld.net/2023/10/20/stocknews-com-downgrades-johnson-johnson-nysejnj-to-buy.html,20231020T071042,['Defense World Staff'],"Johnson & Johnson ( NYSE:JNJ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Wednesday.",https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.284244,Somewhat-Bullish,"[{'ticker': 'JPM', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.07623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.07623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.722944', 'ticker_sentiment_score': '0.433559', 'ticker_sentiment_label': 'Bullish'}]"
KENVUE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301962696.html,20231020T004500,[],KENVUE DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.156899,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.600121', 'ticker_sentiment_score': '0.021496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GCT', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.208112', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.093005', 'ticker_sentiment_label': 'Neutral'}]"
"Myopia Market to Grow at a Substantial Growth Rate During the Study Period  ( 2019-2032 ) , Predicts DelveInsight | Leading Companies - Nevakar, Vyluma, Bausch & Lomb, Sydnexis, Ocumension, ORA, LENZ Therapeutics",https://www.prnewswire.com/news-releases/myopia-market-to-grow-at-a-substantial-growth-rate-during-the-study-period-20192032-predicts-delveinsight--leading-companies---nevakar-vyluma-bausch--lomb-sydnexis-ocumension-ora-lenz-therapeutics-301961706.html,20231019T210100,"['LLP', 'DelveInsight Business Research']","Myopia Market to Grow at a Substantial Growth Rate During the Study Period ( 2019-2032 ) , Predicts DelveInsight ... PR ...",https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.187486,Somewhat-Bullish,"[{'ticker': 'ALC', 'relevance_score': '0.025406', 'ticker_sentiment_score': '0.183471', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BHC', 'relevance_score': '0.025406', 'ticker_sentiment_score': '0.183471', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EYEN', 'relevance_score': '0.025406', 'ticker_sentiment_score': '0.001821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPHF', 'relevance_score': '0.025406', 'ticker_sentiment_score': '0.001821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.050786', 'ticker_sentiment_score': '0.160348', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Invitae Appoints Dr. David Sholehvar as Chief Operating Officer,https://www.prnewswire.com/news-releases/invitae-appoints-dr-david-sholehvar-as-chief-operating-officer-301962415.html,20231019T203000,['Invitae Corporation'],"SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ -- ( NYSE: NVTA ) , a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.",https://mma.prnewswire.com/media/268592/invitae_corporation_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}]",0.236927,Somewhat-Bullish,"[{'ticker': 'III', 'relevance_score': '0.046907', 'ticker_sentiment_score': '0.006971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NEO', 'relevance_score': '0.046907', 'ticker_sentiment_score': '0.069965', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVTA', 'relevance_score': '0.555553', 'ticker_sentiment_score': '0.393547', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DGX', 'relevance_score': '0.046907', 'ticker_sentiment_score': '0.006971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.140076', 'ticker_sentiment_score': '0.008823', 'ticker_sentiment_label': 'Neutral'}]"
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35338096/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,20231019T192006,['Globe Newswire'],"NEW YORK, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.021762,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.691995', 'ticker_sentiment_score': '0.011422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.021477', 'ticker_sentiment_label': 'Neutral'}]"
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35336744/check-out-what-whales-are-doing-with-jnj,20231019T180141,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.092407,Neutral,"[{'ticker': 'BCS', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.800656', 'ticker_sentiment_score': '0.201565', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Global Atherosclerosis Drugs Market Is Projected To Reach $54.8 Billion In 2027 With A CAGR Of 3% As Per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35333824/global-atherosclerosis-drugs-market-is-projected-to-reach-54-8-billion-in-2027-with-a-cagr-of-3-as,20231019T154500,['Globe Newswire'],"LONDON, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Atherosclerosis Drugs Global Market Report 2023, the global atherosclerosis drugs market is poised for significant growth in 2023, with a projected value of $48.72 billion, marking a steady Compound Annual Growth ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.244776,Somewhat-Bullish,"[{'ticker': 'NVS', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.168113', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.072345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.072345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.072345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.072345', 'ticker_sentiment_label': 'Neutral'}]"
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/10/g35332113/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,20231019T150000,['Globe Newswire'],"LOS ANGELES, Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( ""Kenvue"" or the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.021733,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.612343', 'ticker_sentiment_score': '0.039842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.086023', 'ticker_sentiment_label': 'Neutral'}]"
Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem,https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/,20231019T144700,"['JUAN CARLOS ARANCIBIA', ""Investor's Business Daily""]",Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-03-gov.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.055338,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.175009', 'ticker_sentiment_score': '0.326468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.175009', 'ticker_sentiment_score': '-0.021979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.076821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.175009', 'ticker_sentiment_score': '0.012121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LVS', 'relevance_score': '0.1172', 'ticker_sentiment_score': '0.244611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.1172', 'ticker_sentiment_score': '-0.089813', 'ticker_sentiment_label': 'Neutral'}]"
Is Johnson & Johnson Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/10/19/is-johnson-johnson-still-a-good-dividend-stock-to/,20231019T105300,['Cory Renauer'],Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751378%2Finvestment-presentation2-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.236748,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.24847', 'ticker_sentiment_score': '0.133909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.063091', 'ticker_sentiment_score': '-0.073147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.365166', 'ticker_sentiment_score': '0.307675', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Legal tech teams turn to AI to advance business goals,https://www.ft.com/content/9a117ac7-29ae-43fe-b840-a04005b98799,20231019T030041,['Tom Saunders'],Our case studies highlight how the latest tools are helping speed up legal work ...,https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F2b522128-177d-4e59-92b1-c6a29aa5e895.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1,Financial Times,Companies,www.ft.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.250548,Somewhat-Bullish,"[{'ticker': 'INTA', 'relevance_score': '0.021369', 'ticker_sentiment_score': '0.023011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.064047', 'ticker_sentiment_score': '0.121116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRI', 'relevance_score': '0.064047', 'ticker_sentiment_score': '0.098192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.021369', 'ticker_sentiment_score': '0.121192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.021369', 'ticker_sentiment_score': '0.072416', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Stock Flopped Today,https://www.fool.com/investing/2023/10/18/why-johnson-johnson-stock-flopped-today/,20231018T214646,['Eric Volkman'],Perhaps those third-quarter results weren't as impressive as they first appeared to be.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.153837,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.057223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.133841', 'ticker_sentiment_score': '-0.030552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.76191', 'ticker_sentiment_score': '0.302456', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug - Legend Biotech  ( NASDAQ:LEGN ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35314510/positive-outlook-on-johnson-johnsons-partner-legend-biotech-analyst-confident-on-bl,20231018T184406,['Vandana Singh'],"Legend Biotech Corporation's LEGN partner, Johnson & Johnson JNJ, reported Q3 Carvykti revenues of $152 million, up 30% sequentially.",https://cdn.benzinga.com/files/images/story/2023/10/18/legn.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.258632,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.288893', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.421485', 'ticker_sentiment_score': '0.195274', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
The Virology Testing Market Is Expected To Grow At A CAGR Of More Than 9% With Growing Viral Infections Cases As Per The Business Research Company's Virology Testing Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35312142/the-virology-testing-market-is-expected-to-grow-at-a-cagr-of-more-than-9-with-growing-viral-infect,20231018T153000,['Globe Newswire'],"LONDON, Oct. 18, 2023 ( GLOBE NEWSWIRE ) -- The global virology testing market is experiencing significant growth, and the latest market report for 2023 by The Business Research Company reveals an industry poised for substantial expansion.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.26177,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.115639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.115639', 'ticker_sentiment_label': 'Neutral'}]"
"JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus",https://www.zacks.com/stock/news/2168098/jnj-beats-q3-earnings-estimates-raises-view-etfs-in-focus,20231018T140500,['Sweta Killa'],The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.,https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999682'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.240634,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.143987', 'ticker_sentiment_score': '0.150058', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.04823', 'ticker_sentiment_score': '0.288117', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.454714', 'ticker_sentiment_score': '0.370588', 'ticker_sentiment_label': 'Bullish'}]"
1 Warren Buffett Stock to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2023/10/18/1-warren-buffett-stock-to-buy-hand-over-fist-right/,20231018T133000,['George Budwell'],This blue-chip healthcare stock is a solid pick for investors in uncertain times.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751287%2Fgrowth.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.223467,Somewhat-Bullish,"[{'ticker': 'BRK-A', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.15186', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.130926', 'ticker_sentiment_score': '-0.010115', 'ticker_sentiment_label': 'Neutral'}]"
Is American Century U.S. Quality Value ETF  ( VALQ )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2167684/is-american-century-us-quality-value-etf-valq-a-strong-etf-right-now,20231018T102006,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.289018,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.04541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.04541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.114682', 'ticker_sentiment_score': '0.04541', 'ticker_sentiment_label': 'Neutral'}]"
"Is the ""New"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?",https://www.fool.com/investing/2023/10/18/is-the-new-johnson-johnson-stock-a-buy-with-its-im/,20231018T095100,['Keith Speights'],Some things are different about J&J. But other things remain the same as they've been for a long time.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.229228,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.225425', 'ticker_sentiment_score': '0.259152', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.057079', 'ticker_sentiment_score': '-0.039002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.569063', 'ticker_sentiment_score': '0.373567', 'ticker_sentiment_label': 'Bullish'}]"
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors,https://www.fool.com/investing/2023/10/17/johnson-johnsons-sharper-focus-is-already-paying-d/,20231017T200000,['Matthew DiLallo'],The healthcare behemoth reported strong earnings after separating its consumer health division.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F751288%2Fjnj_sankey_q32023.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.999892'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.42835,Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.47452', 'ticker_sentiment_score': '0.55085', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.366061', 'ticker_sentiment_score': '0.528137', 'ticker_sentiment_label': 'Bullish'}]"
"Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher - Bank of America  ( NYSE:BAC ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35295882/back-for-another-round-rate-hike-fears-grow-after-strong-retail-sales-sends-yields-spinning-higher,20231017T183803,['Schwab Center for Financial Research'],( Tuesday market open ) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail Sales raised concerns about another possible rate hike.,https://cdn.benzinga.com/files/images/story/2023/10/17/shutterstock_732185581.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.05773,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.035084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WHR', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.0367', 'ticker_sentiment_score': '-0.055195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.091579', 'ticker_sentiment_score': '0.070621', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.055025', 'ticker_sentiment_score': '0.056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TXN', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.049662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.125822', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TD', 'relevance_score': '0.109789', 'ticker_sentiment_score': '-0.019899', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.055025', 'ticker_sentiment_score': '0.131341', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.109789', 'ticker_sentiment_score': '0.001097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RF', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.049662', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.055025', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.0367', 'ticker_sentiment_score': '-0.026276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.0367', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-rise-in-sales-sharpened-focus-on-innovation-biotech-solutions,20231017T182846,['Lara Goldstein'],"Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",https://cdn.benzinga.com/files/images/story/2023/10/17/company_earnings_commons_-_pexels.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.380922,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.424436', 'ticker_sentiment_label': 'Bullish'}]"
"Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/markets/cannabis/23/10/35295397/johnson-johnsons-q3-2023-21-3b-in-sales-sharpened-focus-on-innovation-biotech-solutions,20231017T182844,['Lara Goldstein'],"Healthcare company Johnson & Johnson ( J&J ) JNJ shared its financial outcomes for the third quarter of 2023, reflecting: Total reported sales of $21,351 million, a 6.8% increase compared to the same period in 2022.",https://cdn.benzinga.com/files/images/story/2023/10/17/company_earnings_commons_-_pexels.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.380922,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.424436', 'ticker_sentiment_label': 'Bullish'}]"
"US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , United Airlines Holdings  ( NASDAQ:UAL ) , Lockheed Martin  ( NYSE:LMT ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/23/10/35284350/us-stock-futures-slide-as-traders-look-past-positive-earnings-news-flow-analysts-predict-year-end-ra,20231017T174627,['Shanthi Rexaline'],"The market mood has turned somber on Tuesday, signaling that stocks could reverse some of the upside seen in the previous session. The bond yields have resumed their climb, with the 10-year U.S. Treasury note yield back above 4.7%, reflecting investor fears concerning further rate hikes.",https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Pixels_Hunter_on_Shutterstock_19.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99676'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.073847,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.022606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.045918', 'ticker_sentiment_score': '0.198223', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACI', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.022606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VSAT', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.208992', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BK', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.091684', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.045918', 'ticker_sentiment_score': '0.062917', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WT', 'relevance_score': '0.045918', 'ticker_sentiment_score': '0.084505', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/10/17/johnson-johnson-jnj-q3-2023-earnings-call-transcri/,20231017T173022,['Motley Fool Transcribing'],"JNJ earnings call for the period ending September 30, 2023.",https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999981'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.314238,Somewhat-Bullish,"[{'ticker': 'GVHIB', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.139057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.107129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.113962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057724', 'ticker_sentiment_score': '0.126025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.031102', 'ticker_sentiment_score': '0.093173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.101192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.004444', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/10/35294426/johnson-johnson-was-saved-by-its-focus-on-medtech-and-innovative-medicine,20231017T171616,['Upwallstreet'],Johnson & Johnson JNJ reported its third quarter results that topped Wall Street's expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses.,https://cdn.benzinga.com/files/medical-banner-with-doctor-wearing-goggles.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.079845,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.088147', 'ticker_sentiment_score': '-0.048514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.21803', 'ticker_sentiment_score': '0.080228', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.21803', 'ticker_sentiment_score': '-0.077784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.342093', 'ticker_sentiment_score': '-0.007579', 'ticker_sentiment_label': 'Neutral'}]"
J&J  ( JNJ )  Beats Q3 Earnings & Sales Estimates Post Spin-Off,https://www.zacks.com/stock/news/2167442/jj-jnj-beats-q3-earnings-sales-estimates-post-spin-off,20231017T163200,['Zacks Equity Research'],J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.,https://staticx-tuner.zacks.com/images/articles/main/6c/385.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Earnings', 'relevance_score': '0.999965'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}]",0.148882,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.14947', 'ticker_sentiment_score': '0.058046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AUPH', 'relevance_score': '0.14947', 'ticker_sentiment_score': '0.089732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MEIP', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.066999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.090021', 'ticker_sentiment_score': '0.057932', 'ticker_sentiment_label': 'Neutral'}]"
"Baby Care Products Market to Touch USD 163.4 billion by 2031, Recording a CAGR of 6.2% | Report by Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35291856/baby-care-products-market-to-touch-usd-163-4-billion-by-2031-recording-a-cagr-of-6-2-report-by-tra,20231017T153000,['Globe Newswire'],"Wilmington, Delaware, United States, Oct. 17, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global baby care products market is projected to flourish at a CAGR of 6.2% from 2021 to 2031. As per the report published by TMR, a valuation of US$ 163.4 billion is anticipated for ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.411007,Bullish,"[{'ticker': 'KMB', 'relevance_score': '0.047465', 'ticker_sentiment_score': '0.231866', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.047465', 'ticker_sentiment_score': '0.231866', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.047465', 'ticker_sentiment_score': '0.231866', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"STERIS'  ( STE )  Improved Volume, New Buyouts Drive Growth",https://www.zacks.com/stock/news/2167341/steris-ste-improved-volume-new-buyouts-drive-growth,20231017T151700,['Zacks Equity Research'],"On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.",https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.9545'}]",0.285607,Somewhat-Bullish,"[{'ticker': 'KMB', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.074052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STE', 'relevance_score': '0.553595', 'ticker_sentiment_score': '0.389146', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.074052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.074052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.077305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.062323', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAE', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.101069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ECL', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.074052', 'ticker_sentiment_label': 'Neutral'}]"
"Dow Jones Flat As Hot Data, Yields Weigh In; Tesla Falls On Fresh Recall",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-hot-data-yields-spook-stocks-tesla-falls-on-fresh-recall/,20231017T151600,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]","Dow Jones Flat As Hot Data, Yields Weigh In. Tesla Falls On Fresh ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2016/06/ECON03_retail_061716_adobe.jpeg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999491'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999483'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.057734,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.132669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VMW', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.058252', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHH', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.160923', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FRO', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.125072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.132669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.058252', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.180514', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.131785', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSHD', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.125072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.05719', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.005626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.257805', 'ticker_sentiment_score': '-0.075043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LBRT', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.125072', 'ticker_sentiment_label': 'Neutral'}]"
Economic News Is More Important Than Earnings Right Now,https://realmoney.thestreet.com/investing/economic-news-is-more-important-than-earnings-right-now-16135714,20231017T151000,"['James ""Rev Shark"" DePorre']","Retail sales numbers were much higher than expected, and all six of the major earnings reports this morning beat on both revenues and EPS. That sounds like a catalyst for a positive market reaction, but what we are seeing is some very strong rotation out of the big-cap technology names and into ...",http://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/64c5278a-ef5d-11e9-848d-857b1f6a04de.jpg,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.176295,Somewhat-Bullish,"[{'ticker': 'ACMR', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.481203', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'RELY', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.279015', 'ticker_sentiment_score': '0.481203', 'ticker_sentiment_label': 'Bullish'}]"
Retail Sales Increased More Than Expected,https://www.zacks.com/stock/news/2167321/retail-sales-increased-more-than-expected,20231017T145400,['Zacks Equity Research'],"This morning we see new Retail Sales numbers for September, and they have come in hotter than expected: headline +0.7% month over month is 50 basis points ( bps ) higher than expected, though down 10 bps from the upwardly revised +0.8% in August.",https://staticx-tuner.zacks.com/images/articles/main/92/476.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.173399,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.145925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.211613', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.155728', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
This 'Boring' Market Is Our Key To 10% Dividend Payouts,https://www.forbes.com/sites/michaelfoster/2023/10/17/this-boring-market-is-our-key-to-10-dividend-payouts/,20231017T143500,['Michael Foster'],"The ""boring"" truth is that what we've been seeing is nothing more than a transition from a panicked market to a more normal one.",https://imageio.forbes.com/specials-images/imageserve/65295bb345ea73cf6ecdaaa8/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.103817,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.085476', 'ticker_sentiment_score': '0.073844', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.085476', 'ticker_sentiment_score': '0.073844', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.070217', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085476', 'ticker_sentiment_score': '0.073844', 'ticker_sentiment_label': 'Neutral'}]"
"Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3",https://www.zacks.com/stock/news/2167302/retail-sales-hotter-at-07-jnj-bac-gs-all-beat-in-q3,20231017T143200,['Mark Vickery'],"Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.",https://staticx-tuner.zacks.com/images/articles/main/ab/505.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.163949,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.147818', 'ticker_sentiment_score': '0.149788', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.220141', 'ticker_sentiment_score': '0.197845', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.147818', 'ticker_sentiment_score': '0.149788', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson lifts profit outlook on strong demand for top-seller Stelara,https://www.foxbusiness.com/markets/johnson-johnson-lifts-profit-outlook-strong-demand-top-seller-stelara,20231017T140450,['Reuters'],"Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara. The company's shares were up about 2% in premarket trading on ...",https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/c757b7f7-5a24-4e53-86bd-eaafafd5dd2c/8d4419ea-3121-4536-ac3a-ad66e049ed58/1280x720/match/image.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.224422,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.07913', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.07913', 'ticker_sentiment_score': '0.059833', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.234307', 'ticker_sentiment_score': '0.137139', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard",https://www.fool.com/investing/2023/10/17/johnson-johnson-is-falling-but-this-tech-stock-is/,20231017T140022,['Dan Caplinger'],Earnings season is starting to ramp up.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.09105,Neutral,"[{'ticker': 'VMW', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.028618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.040791', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.399204', 'ticker_sentiment_score': '0.251898', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/10/17/top-10-things-to-watch-in-the-stock-market-tuesday.html,20231017T131108,['Jeff Marks'],U.S. stocks are set to open lower on Tuesday as bond yields rise.,https://image.cnbcfm.com/api/v1/image/107305168-1695391812680-gettyimages-1695425858-aca0db9d-1d95-4527-96d5-ebd4634e0c63.jpeg?v=1697548268&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999499'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.170587,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.099945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.144598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DLTR', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.026503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.180685', 'ticker_sentiment_score': '-0.008753', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCTZF', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.088002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LIN', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.239303', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.070446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APD', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.239303', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EBAY', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.244074', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'W', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CART', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.121037', 'ticker_sentiment_score': '-0.082887', 'ticker_sentiment_label': 'Neutral'}]"
J&J Raises Outlook As Health Bellwether Tries To Reinvent Itself,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q3-2023/,20231017T130500,"[""Investor's Business Daily"", 'ALLISON GATLIN']",JNJ Stock: Health Care Bellwether Boosts Outlook As It Refocuses ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/01/Stock-JohnsonAndJohnson-syringe-shut.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.327439,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.368734', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MRNA', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.018124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.018124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.018124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.880871', 'ticker_sentiment_score': '0.573042', 'ticker_sentiment_label': 'Bullish'}]"
Stock market today: Wall Street inches back as war in the Middle East hangs over markets,https://apnews.com/article/stock-markets-earnings-china-war-69e60cda4b5adde06417e5822870837d,20231017T121400,"['MATT OTT', 'ELAINE KURTENBACH']","Wall Street pointed toward losses early Tuesday as corporate earnings roll in and worries about war in the Middle East hang over markets. Futures for the S&P 500 and Dow industrials slipped 0.2% before the bell. In addition to another heavy slate of quarterly earnings, the U.S. will release ...",https://dims.apnews.com/dims4/default/46893e0/2147483647/strip/true/crop/4162x2772+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fb2%2F8b%2F9730f2c49f858bb9797944f27631%2Fa09381e771a34a2c80cdd8bac55fb3b7,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",-0.143879,Neutral,"[{'ticker': 'WH', 'relevance_score': '0.06211', 'ticker_sentiment_score': '-0.13005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHH', 'relevance_score': '0.06211', 'ticker_sentiment_score': '-0.13005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.164097', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.170637', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.164097', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.123844', 'ticker_sentiment_score': '-0.156444', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.06211', 'ticker_sentiment_score': '-0.136057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.06211', 'ticker_sentiment_score': '-0.136057', 'ticker_sentiment_label': 'Neutral'}]"
"The daily business briefing: October 17, 2023",https://theweek.com/business/the-daily-business-briefing-october-17-2023,20231017T115616,"['The Week US', 'Harold Maass']",2. Lululemon shares jump after joining S&P 500 3. Stock futures struggle as earnings season picks up 4. China tells banks to ease municipal debt burdens 5. Survey says shoppers expect to spend more this year,https://cdn.mos.cms.futurecdn.net/xHpwKWhfea6hE9SwMmaAmG-415-80.jpg,The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}]",-0.021761,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.052537', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.018281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRNWF', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.055383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.060135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RAD', 'relevance_score': '0.033236', 'ticker_sentiment_score': '-0.177258', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'XOM', 'relevance_score': '0.033236', 'ticker_sentiment_score': '-0.1139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.072698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.033236', 'ticker_sentiment_score': '0.028903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIRK', 'relevance_score': '0.033236', 'ticker_sentiment_score': '-0.10993', 'ticker_sentiment_label': 'Neutral'}]"
"New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/10/35283724/new-johnson-johnsons-q3-earnings-beat-street-view-raises-annual-outlook,20231017T115326,['Vandana Singh'],"Johnson & Johnson JNJ has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the consensus of $2.51. Sales increased 6.8% to $21.35 billion, beating the consensus of $21.04 billion, with operational growth of 7.5 and adjusted operational growth of 6.4%.",https://cdn.benzinga.com/files/images/story/2023/10/17/jnjioffice3.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.222662,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.518292', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.82082', 'ticker_sentiment_score': '0.504831', 'ticker_sentiment_label': 'Bullish'}]"
Johnson & Johnson  ( JNJ )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2166934/johnson-johnson-jnj-q3-earnings-and-revenues-surpass-estimates,20231017T114002,['Zacks Equity Research'],"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default138.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.150803,Somewhat-Bullish,"[{'ticker': 'PFE', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.395012', 'ticker_sentiment_score': '0.1105', 'ticker_sentiment_label': 'Neutral'}]"
Tupperware Brands Announces CEO Transition and Board Refreshment - PR Newswire,https://www.prnewswire.com/news-releases/tupperware-brands-announces-ceo-transition-and-board-refreshment-301958827.html,20231017T113000,[],Tupperware Brands Announces CEO Transition and Board Refreshment PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}]",0.276926,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.192135', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.010123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RAD', 'relevance_score': '0.028937', 'ticker_sentiment_score': '-0.006524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSMRF', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.023681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLX', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.033406', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EVRG', 'relevance_score': '0.028937', 'ticker_sentiment_score': '-0.006524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.023681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EWCZ', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.010123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEWOW', 'relevance_score': '0.028937', 'ticker_sentiment_score': '-0.006524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICNB', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.310522', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NUS', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.023681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TUP', 'relevance_score': '0.228341', 'ticker_sentiment_score': '0.225119', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Invest in millennials and these 'one-in-a-lifetime opportunity' stocks, says this fund manager",https://www.marketwatch.com/story/invest-in-millennials-and-these-one-in-a-lifetime-opportunity-stocks-says-this-fund-manager-cc5420c4,20231017T105200,['Barbara Kollmeyer'],Our call of the day offers bargains among energy and stocks catering to future millennial spending.,https://images.mktw.net/im-869859?width=700&height=479,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.112337,Neutral,"[{'ticker': 'OXY', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.183155', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.043497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COP', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.183155', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.043497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.043497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UHAL', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IDIG', 'relevance_score': '0.04111', 'ticker_sentiment_score': '0.061061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.038629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.04111', 'ticker_sentiment_score': '0.153649', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge",https://www.cnbc.com/2023/10/17/johnson-johnson-jnj-q3-earnings-report-2023.html,20231017T102515,['Annika Kim Constantino'],It marks J&J's first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.,https://image.cnbcfm.com/api/v1/image/106974803-1636726862899-gettyimages-1164570932-AFP_1JU2A3.jpeg?v=1697538315&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.112428,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.255641', 'ticker_sentiment_score': '-0.151979', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
J&J raises annual profit forecast on anti-inflammatory drug demand,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-strong-cancer-drug-demand-2023-10-17/,20231017T102457,['Reuters'],"The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. REUTERS/Yves Herman/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/XJJTNMLU6FPZLDD3S7GYM3JVWU.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.340601,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.591019', 'ticker_sentiment_score': '0.385262', 'ticker_sentiment_label': 'Bullish'}]"
Genmab Announces Net Sales of DARZALEX®  ( daratumumab )  for Third Quarter of 2023,https://www.globenewswire.com/news-release/2023/10/17/2761310/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Third-Quarter-of-2023.html,20231017T102200,['Genmab A/S'],Company Announcement ...,https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.050362,Neutral,"[{'ticker': 'GMAB', 'relevance_score': '0.665529', 'ticker_sentiment_score': '0.093273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.011568', 'ticker_sentiment_label': 'Neutral'}]"
"Morning Bid: Banks, Biden visit buoy markets",https://www.reuters.com/markets/us/global-markets-view-usa-2023-10-17/,20231017T100100,['Reuters'],"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., August 15, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/UQEJIZSJ4FLI7JVPW2KKX7XCDY.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.028984,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.128815', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.095707', 'ticker_sentiment_score': '0.088196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.128815', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.128815', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.095707', 'ticker_sentiment_score': '0.088196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLD', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.325955', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.095707', 'ticker_sentiment_score': '0.088196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.099001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.04794', 'ticker_sentiment_score': '0.147003', 'ticker_sentiment_label': 'Neutral'}]"
S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited,https://www.marketwatch.com/story/s-p-500-futures-drift-as-goldman-sachs-and-bank-of-america-earnings-awaited-dfd86d7b,20231017T085100,['Jamie Chisholm'],U.S. stock futures show Wall Street holding most of the rally from the start of the week as investors display less anxiety about geopolitical risk.,https://images.mktw.net/im-869445/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.150372,Somewhat-Bullish,"[{'ticker': 'IBKR', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.060631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.060631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.060631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.060631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HRGLF', 'relevance_score': '0.077845', 'ticker_sentiment_score': '0.207393', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.154951', 'ticker_sentiment_score': '0.060631', 'ticker_sentiment_label': 'Neutral'}]"
"Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/10/35280111/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday,20231017T074554,['Lisa Levin'],"With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson JNJ to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell.",https://cdn.benzinga.com/files/images/story/2023/10/17/image12.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}]",0.09356,Neutral,"[{'ticker': 'XXII', 'relevance_score': '0.501398', 'ticker_sentiment_score': '-0.487426', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NTCT', 'relevance_score': '0.501398', 'ticker_sentiment_score': '-0.314589', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAC', 'relevance_score': '0.501398', 'ticker_sentiment_score': '0.320601', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.501398', 'ticker_sentiment_score': '0.559502', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.501398', 'ticker_sentiment_score': '0.559502', 'ticker_sentiment_label': 'Bullish'}]"
Johnson & Johnson earnings: What to expect,https://www.marketwatch.com/story/johnson-johnson-earnings-what-to-expect-ee9e4a13,20231017T071300,['Ciara Linnane'],Drug and medtech company is posting third-quarter earnings before the bell on Tuesday.,https://images.mktw.net/im-757874/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.109174,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.463792', 'ticker_sentiment_score': '0.36223', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.046716', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.357293', 'ticker_sentiment_score': '0.303784', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Asia stocks rise on earnings hopes; keep wary eye on Middle east tensions,https://www.moneycontrol.com/news/business/markets/asia-stocks-rise-on-earnings-hopes-keep-wary-eye-on-middle-east-tensions-11544961.html,20231017T041226,[],MSCI's broadest index of Asia-Pacific shares outside Japan advanced 0.4%. Tokyo's Nikkei rose 1%.,https://images.moneycontrol.com/static-mcnews/2019/07/Asian-Markets.jpg?impolicy=website&width=168&height=118,Money Control,Markets,www.moneycontrol.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.818451'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.024554,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.187947', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRYF', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.092025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:AUD', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.134356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.22421', 'ticker_sentiment_score': '-0.298006', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.187947', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Asia stocks rise on earnings hopes; keep wary eye on Mideast tensions,https://www.reuters.com/markets/global-markets-wrapup-1-2023-10-17/,20231017T033239,['Selena Li'],Asia stocks rise on earnings hopes. keep wary eye on Mideast tensions ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/3YNMXI5NLZJHPH242XBLXFFGBA.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.024458,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.185568', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRYF', 'relevance_score': '0.068306', 'ticker_sentiment_score': '-0.090961', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:AUD', 'relevance_score': '0.068306', 'ticker_sentiment_score': '-0.132693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.202932', 'ticker_sentiment_score': '-0.273762', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.185568', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Bitcoin, Ethereum, Dogecoin Spike As False BlackRock ETF Rumor Sparks $104M Shorts Liquidation: Analyst Says 'Real Tweet Would Do So Much More' - BlackRock  ( NYSE:BLK ) ",https://www.benzinga.com/markets/cryptocurrency/23/10/35279325/bitcoin-ethereum-dogecoin-spike-as-false-blackrock-etf-rumor-sparks-104m-shorts-liquidatio,20231017T023952,['Mehab Qureshi'],"Major cryptocurrencies experienced a significant surge on Monday evening, triggered by a false rumor on X, claiming that the Securities and Exchange Commission ( SEC ) had approved BlackRock's BLK spot bitcoin ETF application.",https://cdn.benzinga.com/files/images/story/2023/Bitcoin_9.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.995921'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}]",0.159981,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.196344', 'ticker_sentiment_score': '0.050249', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.079114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.079114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.079114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.066047', 'ticker_sentiment_score': '0.079114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.592742', 'ticker_sentiment_score': '0.12254', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street ends up on earnings optimism; eyes remain on Middle East,https://www.moneycontrol.com/news/business/markets/wall-street-ends-up-on-earnings-optimism-eyes-remain-on-middle-east-11543891.html,20231017T004845,[],"Market participants were monitoring the Israeli war in Gaza, but appeared to be taking more of a risk-on stance on Monday, with safe-haven gold prices down.",https://images.moneycontrol.com/static-mcnews/2021/01/Wall-Street_reuters.jpg?impolicy=website&width=168&height=118,Money Control,Markets,www.moneycontrol.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}]",0.07683,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.178924', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.178924', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCHW', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.173357', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LPLA', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.150332', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.078354', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Markets Pop on Bargain Hunting, Stronger Economy",https://www.zacks.com/stock/news/2166817/markets-pop-on-bargain-hunting-stronger-economy,20231016T224200,['Zacks Investment Research'],"The small-cap Russell 2000, still under water over the past month, led the way higher today.",https://staticx-tuner.zacks.com/images/articles/main/81/48849.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.148243,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.036241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.036241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.036241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ETSY', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.101763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.036241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.036241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.101763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.101763', 'ticker_sentiment_label': 'Neutral'}]"
Futures: Market Rally Snaps Back With Big Gains,https://www.investors.com/market-trend/stock-market-today/dow-jones-rallies-market-rally-snaps-back-netflix-nvidia-tesla-in-focus/,20231016T211100,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']",Dow Jones Rallies 300 Points As Market Rally Snaps Back. Netflix ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/10/stock-wall-street-flags-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.148112,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.12351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.137868', 'ticker_sentiment_score': '0.030835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.171851', 'ticker_sentiment_score': '-0.125093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.184966', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.103628', 'ticker_sentiment_score': '0.109286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.137868', 'ticker_sentiment_score': '0.047306', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.184966', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.069194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.171851', 'ticker_sentiment_score': '0.106864', 'ticker_sentiment_label': 'Neutral'}]"
"Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech",https://www.prnewswire.com/news-releases/large-granular-lymphocyte-leukemia-market-is-projected-to-grow-during-the-study-period-20192032-assesses-delveinsight--key-companies---bristol-myers-squibb-innate-pharma-kymera-therapeutics-eusa-pharma-abcuro-dren-bio-n-301957023.html,20231016T210100,"['LLP', 'DelveInsight Business Research']","Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period ( 2019-2032 ) , Assesses ... PR ...",https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.069381,Neutral,"[{'ticker': 'IPHA', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.095897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.032245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.028928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LVTX', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KYMR', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.095897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TGTX', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.077426', 'ticker_sentiment_score': '-0.029504', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ONCT', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APVO', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.023726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NRIX', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.028928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APRE', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.026539', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.023726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.025845', 'ticker_sentiment_score': '-0.023726', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson's Earnings Will Offer a Look at the Company Without Kenvue,https://www.barrons.com/articles/johnson-jnj-earnings-stock-price-20d516cc,20231016T210000,['Josh Nathan-Kazis'],Johnson & Johnson's Earnings Are Coming. They'll Be the First ... ...,https://images.barrons.com/im-17614305/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.0,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
4 Hot Penny Stocks To Watch With The Stock Market Up Today,https://pennystocks.com/featured/2023/10/16/4-hot-penny-stocks-to-watch-with-the-stock-market-up-today/,20231016T174327,['J. Phillip'],"Whether you're trading penny stocks or stocks over $100, it's hard to miss that the stock market is up today. That's in stark contrast to last week, when markets appeared to be heading toward another downtrend.",https://pennystocks.com/wp-content/uploads/2022/07/best-penny-stocks-to-watch-right-now.jpg,PennyStocks.com,n/a,pennystocks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.187232,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MNTS', 'relevance_score': '0.158259', 'ticker_sentiment_score': '0.259889', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.14224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPCE', 'relevance_score': '0.119038', 'ticker_sentiment_score': '0.100293', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAVE', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.168359', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FUBO', 'relevance_score': '0.158259', 'ticker_sentiment_score': '0.10182', 'ticker_sentiment_label': 'Neutral'}]"
"Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, but Middle East Worries Dominate - Apple  ( NASDAQ:AAPL ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35272437/pendulum-swings-markets-recover-slightly-after-fridays-anxious-trading-but-middle-east-worries-domin,20231016T170715,['Schwab Center for Financial Research'],"( Monday market open ) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report. And the main course might be Wednesday afternoon when Netflix NFLX and Tesla TSLA open their books.",https://cdn.benzinga.com/files/images/story/2023/10/16/shutterstock_534464629_6.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Financial Markets', 'relevance_score': '0.999995'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999989'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.067779,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.090679', 'ticker_sentiment_score': '0.006231', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.0726', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.036461', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.036338', 'ticker_sentiment_score': '-0.081306', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTRS', 'relevance_score': '0.036338', 'ticker_sentiment_score': '-0.117215', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.090679', 'ticker_sentiment_score': '-0.024393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.082244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.0726', 'ticker_sentiment_score': '-0.081525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.0726', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZIONL', 'relevance_score': '0.018173', 'ticker_sentiment_score': '-0.106918', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.0726', 'ticker_sentiment_score': '-0.016156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.0726', 'ticker_sentiment_score': '-0.087575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.019806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RF', 'relevance_score': '0.0726', 'ticker_sentiment_score': '-0.106746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.031027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.015988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.050374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.036338', 'ticker_sentiment_score': '-0.026246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.0726', 'ticker_sentiment_score': '-0.064009', 'ticker_sentiment_label': 'Neutral'}]"
"Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending - Bank of America  ( NYSE:BAC ) , American Express  ( NYSE:AXP ) ",https://www.benzinga.com/news/earnings/23/10/35272066/mondays-market-minute-this-weeks-focus-earnings-consumer-spending,20231016T164605,['Schwab Network'],The focus for investors and traders will shift from inflation after the higher-than-expected figures last week to earnings and consumer spending habits.,https://cdn.benzinga.com/files/images/story/2023/10/16/shutterstock_1978695896_13.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",-0.037954,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UAL', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.172999', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Wall Street Waits for Big Earnings Results,https://www.zacks.com/stock/news/2166555/wall-street-waits-for-big-earnings-results,20231016T145700,['Zacks Equity Research'],"It's a busy trading week ahead, with Q3 earnings season heating up and more economic data being released a couple weeks ahead of the next Federal Open Market Committee ( FOMC ) meeting, which decides on interest rates.",https://staticx-tuner.zacks.com/images/articles/main/98/601.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.13292,Neutral,"[{'ticker': 'SCHW', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.161935', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.043266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.043266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.043266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.043266', 'ticker_sentiment_label': 'Neutral'}]"
Empire State Less Bad than Expected; SCHW Mixed in Q3,https://www.zacks.com/stock/news/2166539/empire-state-less-bad-than-expected-schw-mixed-in-q3,20231016T142700,['Mark Vickery'],"We've only seen four months in positive territory on Empire State manufacturing year to date, the highest being +10.8 in April.",https://staticx-tuner.zacks.com/images/articles/main/ac/1026.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.132866,Neutral,"[{'ticker': 'SCHW', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.158778', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.042404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.042404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.042404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.204936', 'ticker_sentiment_score': '0.042404', 'ticker_sentiment_label': 'Neutral'}]"
"White River Bancshares Co. Earns $639,000, or $0.64 Per Diluted Share, in Third Quarter 2023; Highlighted by Double Digit Loan and Deposit Growth Year-Over-year",https://www.globenewswire.com/news-release/2023/10/16/2760706/0/en/White-River-Bancshares-Co-Earns-639-000-or-0-64-Per-Diluted-Share-in-Third-Quarter-2023-Highlighted-by-Double-Digit-Loan-and-Deposit-Growth-Year-Over-year.html,20231016T130000,['White River Bancshares'],"FAYETTEVILLE, Ark., Oct. 16, 2023 ( GLOBE NEWSWIRE ) -- White River Bancshares Company ( OTCQX: WRIV ) , ( the ""Company"" ) the holding company for Signature Bank of Arkansas ( the ""Bank"" ) , today reported net income of $639,000, or $0.64 per diluted share, in the third quarter of 2023, compared ...",https://ml.globenewswire.com/Resource/Download/59f98c26-e808-41b4-b248-610c5133e898,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",0.208887,Somewhat-Bullish,"[{'ticker': 'KO', 'relevance_score': '0.016271', 'ticker_sentiment_score': '0.116446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.065017', 'ticker_sentiment_score': '0.102122', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.016271', 'ticker_sentiment_score': '0.116446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.016271', 'ticker_sentiment_score': '0.116446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.016271', 'ticker_sentiment_score': '0.116446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.016271', 'ticker_sentiment_score': '0.116446', 'ticker_sentiment_label': 'Neutral'}]"
Innovation Takes Center Stage: Florida's Life Sciences Leaders Shine at BioFlorida Conference,https://www.prnewswire.com/news-releases/innovation-takes-center-stage-floridas-life-sciences-leaders-shine-at-bioflorida-conference-301957464.html,20231016T123800,['BioFlorida'],The Annual Conference Fuels Growth with a Focus on Elevating Florida's Position on the Global Stage,https://mma.prnewswire.com/media/2247700/BioFlorida_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.34544,Somewhat-Bullish,"[{'ticker': 'CVKD', 'relevance_score': '0.057147', 'ticker_sentiment_score': '0.07', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028592', 'ticker_sentiment_score': '0.198867', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GLOB', 'relevance_score': '0.028592', 'ticker_sentiment_score': '0.166429', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SZCRF', 'relevance_score': '0.014298', 'ticker_sentiment_score': '0.050969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPRX', 'relevance_score': '0.042876', 'ticker_sentiment_score': '0.32357', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.028592', 'ticker_sentiment_score': '0.198867', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HRZN', 'relevance_score': '0.028592', 'ticker_sentiment_score': '0.134959', 'ticker_sentiment_label': 'Neutral'}]"
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation,https://www.fool.com/investing/2023/10/16/4-dividend-stocks-yield-4-buy-without-hesitation/,20231016T121200,['Matthew DiLallo'],These stocks offer attractive payouts that should rise in the future.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",0.343006,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.222022', 'ticker_sentiment_score': '0.326257', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'STAG', 'relevance_score': '0.134339', 'ticker_sentiment_score': '0.23903', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SO', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.232696', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.199687', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"The daily business briefing: October 16, 2023",https://theweek.com/business/the-daily-business-briefing-october-16-2023,20231016T120957,"['The Week US', 'Harold Maass']","2. Taylor Swift's concert movie breaks records 3. Dow, S&P edge higher ahead of wave of earnings 5. Pfizer cuts forecast for Covid vaccine, therapy sales A free daily digest of the biggest news stories of the day - and the best features from our website Thank you for signing up to TheWeek.",https://cdn.mos.cms.futurecdn.net/YSghz4sVxEeV4uzDD3m96B-415-80.jpg,The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",-0.009662,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.008567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.089797', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.008567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.008567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.008567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.033282', 'ticker_sentiment_score': '-0.13329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.052548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.099614', 'ticker_sentiment_score': '-0.026246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.008567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.099614', 'ticker_sentiment_score': '-0.004384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.089797', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRNWF', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.055395', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.066506', 'ticker_sentiment_score': '0.023091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RAD', 'relevance_score': '0.099614', 'ticker_sentiment_score': '-0.148968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.066506', 'ticker_sentiment_score': '0.003023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.033282', 'ticker_sentiment_score': '-0.113922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.033282', 'ticker_sentiment_score': '0.090704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIRK', 'relevance_score': '0.033282', 'ticker_sentiment_score': '-0.109932', 'ticker_sentiment_label': 'Neutral'}]"
TREMFYA®  ( guselkumab )  Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study,https://markets.businessinsider.com/news/stocks/tremfya-guselkumab-maintains-key-efficacy-endpoints-through-three-years-for-adults-with-moderately-to-severely-active-crohn-s-disease-in-a-phase-2-study-1032708159,20231016T120100,['markets.businessinsider.com'],TREMFYA® (guselkumab) Maintains Key Efficacy Endpoints Through Three Years for Adults with Moderately to Severely Active Crohn's Disease in a Phase 2 Study ...,https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.038824,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.10974', 'ticker_sentiment_label': 'Neutral'}]"
Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ESMO,https://markets.businessinsider.com/news/stocks/janssen-aims-to-define-new-standards-of-care-in-the-treatment-of-solid-tumor-cancers-with-transformative-data-planned-for-presentation-at-esmo-1032708126,20231016T120000,['markets.businessinsider.com'],Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ...,https://c212.net/c/img/favicon.png?sn=AQ31152&sd=2023-10-16,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.057784,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.028109', 'ticker_sentiment_score': '-0.050847', 'ticker_sentiment_label': 'Neutral'}]"
Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in Myasthenia Gravis at AANEM 2023 Meeting,https://www.prnewswire.com/news-releases/janssen-to-highlight-latest-research-from-nipocalimab-clinical-development-program-to-address-unmet-need-in-myasthenia-gravis-at-aanem-2023-meeting-301957084.html,20231016T120000,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in ... PR ...,https://mma.prnewswire.com/media/2193913/jsn_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.014468,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.185917', 'ticker_sentiment_score': '-0.009305', 'ticker_sentiment_label': 'Neutral'}]"
"TSX futures kick off week on copper boost, Middle East conflict weighs",https://www.reuters.com/markets/tsx-futures-kick-off-week-copper-boost-middle-east-conflict-weighs-2023-10-16/,20231016T114900,['Reuters'],"The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto, Ontario, Canada January 23, 2019. REUTERS/Chris Helgren/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/STWPE5MPBNIFROJQ5NZIJRD6X4.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.021632,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTKBF', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.24409', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year - Netflix  ( NASDAQ:NFLX ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , NVIDIA  ( NASDAQ:NVDA ) , Tesla  ( NASDAQ:TSLA ) ",https://www.benzinga.com/news/earnings/23/10/35263899/us-stocks-on-track-for-a-strong-start-to-week-buoyed-by-earnings-optimism-analyst-flags-13-14-upsid,20231016T113407,['Shanthi Rexaline'],"Earnings optimism has kept sentiment buoyant, with the stock futures pointing to a higher opening on Monday. The third-quarter earnings season starts in earnest this week, with some blue chip companies, including Tesla, Inc. TSLA, Netflix, Inc.",https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Jirapong_Manustrong_on_Shutterstock_28.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.999499'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}]",0.052859,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.179311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.050254', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.149966', 'ticker_sentiment_score': '0.132041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.179311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.179311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCHW', 'relevance_score': '0.100308', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.050254', 'ticker_sentiment_score': '0.219344', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVAX', 'relevance_score': '0.100308', 'ticker_sentiment_score': '-0.084608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.050254', 'ticker_sentiment_score': '0.14925', 'ticker_sentiment_label': 'Neutral'}]"
Is iShares Core Dividend Growth ETF  ( DGRO )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2166224/is-ishares-core-dividend-growth-etf-dgro-a-strong-etf-right-now,20231016T102006,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default267.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999986'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.300328,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.101971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.06109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.179932', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.06109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.06109', 'ticker_sentiment_label': 'Neutral'}]"
Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD 2487.63 Million Value by 2030 with a Notable CAGR of 5.25%,https://www.prnewswire.com/news-releases/infinium-global-research-forecasts-robust-growth-in-ophthalmic-surgical-technologies-market-anticipates-usd-2487-63-million-value-by-2030-with-a-notable-cagr-of-5-25-301957269.html,20231016T100000,['Infinium Global Research'],Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD ... PR ...,https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.219009,Somewhat-Bullish,"[{'ticker': 'SNPHF', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STAA', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALC', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'III', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.167968', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GKOS', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOPCF', 'relevance_score': '0.04882', 'ticker_sentiment_score': '0.092574', 'ticker_sentiment_label': 'Neutral'}]"
"Futures up ahead of earnings and data, Middle East tensions weigh",https://www.reuters.com/markets/us/futures-up-ahead-earnings-data-middle-east-tensions-weigh-2023-10-16/,20231016T095600,['Reuters'],"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 28, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/32DHT533XJKJDP3XVC5KVAMRUY.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.044985,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.085324', 'ticker_sentiment_score': '-0.185896', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.085324', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.085324', 'ticker_sentiment_score': '-0.295459', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE,https://www.benzinga.com/pressreleases/23/10/g35258709/technicolor-creative-studios-strengthens-its-leadership-structure,20231016T060426,['Globe Newswire'],"Paris ( France ) , October 16, 2023 - Technicolor Creative Studios ( TCS ) announces the evolution of its Executive Committee with: The appointment of Michael Masset as Chief People Officer The extension of Stéphanie Fougou's portfolio of responsibilities with the inclusion of the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.406678,Bullish,"[{'ticker': 'MAT', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.106387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACRFF', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.125389', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VLOUF', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.125389', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPIF', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.112199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXBGY', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.073653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.106387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.106387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.106387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.106387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CREAF', 'relevance_score': '0.033751', 'ticker_sentiment_score': '0.219281', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
TECHNICOLOR CREATIVE STUDIOS STRENGTHENS ITS LEADERSHIP STRUCTURE,https://www.globenewswire.com/news-release/2023/10/16/2760308/0/en/TECHNICOLOR-CREATIVE-STUDIOS-STRENGTHENS-ITS-LEADERSHIP-STRUCTURE.html,20231016T060400,['Technicolor Creative Studios'],PRESS RELEASE ...,https://ml-eu.globenewswire.com/Resource/Download/b42a1545-5237-4d78-a9db-63a0b497f310,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.400658,Bullish,"[{'ticker': 'MAT', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.106346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACRFF', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.125349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VLOUF', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.125349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPIF', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.112156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXBGY', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.073622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.106346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.106346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.106346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.106346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CREAF', 'relevance_score': '0.033656', 'ticker_sentiment_score': '0.292162', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Wall Street's Q3 expectations have been all over the place. Now, a swing to profit growth is 'likely' - with a bigger rebound next year",https://www.marketwatch.com/story/wall-streets-q3-expectations-have-been-all-over-the-place-now-a-swing-to-profit-growth-is-likely-with-a-bigger-rebound-next-year-d12282de,20231015T143100,['Bill Peters'],One analyst who tracks the ebbs and flows of earnings data says at least a slight profit gain for the third quarter is more likely.,https://images.mktw.net/im-868495/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999326'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.178294,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.153797', 'ticker_sentiment_score': '0.142829', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.102888', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.153797', 'ticker_sentiment_score': '-0.016073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.116921', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.153797', 'ticker_sentiment_score': '0.079337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.102888', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.102888', 'ticker_sentiment_score': '-0.066278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.102888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.102888', 'ticker_sentiment_score': '0.157606', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DFS', 'relevance_score': '0.102888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.153797', 'ticker_sentiment_score': '0.142074', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'T', 'relevance_score': '0.051551', 'ticker_sentiment_score': '-0.060909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.102888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.102888', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Why You Should Invest In Healthcare Stocks,https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks,20231015T140059,['James K. Glassman'],"Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.",https://cdn.mos.cms.futurecdn.net/KKJr2NN3xukR5Kxuhz2vrY-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.99737'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.183015,Somewhat-Bullish,"[{'ticker': 'SYK', 'relevance_score': '0.099752', 'ticker_sentiment_score': '0.18093', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ILMN', 'relevance_score': '0.066598', 'ticker_sentiment_score': '0.119713', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.099752', 'ticker_sentiment_score': '0.087475', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.066598', 'ticker_sentiment_score': '0.0641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.066598', 'ticker_sentiment_score': '-0.162455', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'IVZ', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.12656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.099752', 'ticker_sentiment_score': '-0.01214', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.099752', 'ticker_sentiment_score': '0.276915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.066598', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.132733', 'ticker_sentiment_score': '0.109596', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.033328', 'ticker_sentiment_score': '-0.068677', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WST', 'relevance_score': '0.066598', 'ticker_sentiment_score': '0.068343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AUGX', 'relevance_score': '0.099752', 'ticker_sentiment_score': '-0.041137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.066598', 'ticker_sentiment_score': '0.068343', 'ticker_sentiment_label': 'Neutral'}]"
3 Dividend Growth Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/10/14/3-dividend-growth-stocks-you-can-buy-and-hold-fore/,20231014T105200,"['Keith Speights', 'and Prosper Junior Bakiny', 'David Jagielski']",Investors can sit back and let the dividends flow in with these great stocks.,https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.803643'}]",0.201977,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.353338', 'ticker_sentiment_score': '0.11404', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.278561', 'ticker_sentiment_score': '0.130001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.316337', 'ticker_sentiment_score': '0.229411', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Kenvue Inc.: Please contact the Portnoy Law Firm to recover your losses; December 8, 2023 deadline - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35251596/kenvue-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-december-8-2023-deadline,20231014T014246,['Globe Newswire'],Investors can contact the law firm at no cost to learn more about recovering their losses,https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",-0.026674,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.450165', 'ticker_sentiment_score': '0.0091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.079392', 'ticker_sentiment_score': '0.128105', 'ticker_sentiment_label': 'Neutral'}]"
Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... - PR Newswire,https://www.prnewswire.com/news-releases/brazil---cosmetics-market-size-to-increase-by-usd-4-72-billion-between-2022-to-2027-rise-in-sales-of-cosmetics-through-e-commerce-channels-drives-the-market-growth---technavio-301955600.html,20231013T233500,[],Brazil - Cosmetics Market size to increase by USD 4.72 billion between 2022 to 2027| Rise in sales of cosmetics ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.275801,Somewhat-Bullish,"[{'ticker': 'BDRFF', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KAOCF', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSDOF', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HENKY', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMRSQ', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COTY', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... - PR Newswire,https://www.prnewswire.com/news-releases/ent-devices-market-size-to-grow-by-usd-8-83-billion-from-2022-2027-market-is-fragmented-by-major-companies-like-baxter-international-inc-siemens-healthineers-ag-johnson-and-johnson-and-much-more---technavio-301955602.html,20231013T231500,[],ENT Devices Market size to grow by USD 8.83 billion from 2022-2027| Market is fragmented by major companies like ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.194001,Somewhat-Bullish,"[{'ticker': 'SYK', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHEOF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOCPF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEMHF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OCPNF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPBY', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SONVF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WILLF', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.152018', 'ticker_sentiment_score': '0.065042', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.059606', 'ticker_sentiment_label': 'Neutral'}]"
Weekly Roundup,https://aap.thestreet.com/story/16135510/1/weekly-roundup.html,20231013T225600,[],"Before the week even started, we knew it had the potential to be volatile. We had just come off the September jobs report that surprised with its stunning strength, and we had the consumer and producer price index reports that would land, filling out the picture on inflation.",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/91fbc74f-6a0d-11ee-9691-b5f85aa22ae6.png,The Street,GoogleRSS,aap.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999973'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.161329,Somewhat-Bullish,"[{'ticker': 'HRL', 'relevance_score': '0.003607', 'ticker_sentiment_score': '-0.019654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.021637', 'ticker_sentiment_score': '0.041278', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRIN', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.054415', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ROAD', 'relevance_score': '0.010819', 'ticker_sentiment_score': '0.097441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.057441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELV', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.003607', 'ticker_sentiment_score': '-0.019188', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VFC', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.057441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.010819', 'ticker_sentiment_score': '0.061732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.095943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHKP', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.016071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRBT', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.026473', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OLED', 'relevance_score': '0.043257', 'ticker_sentiment_score': '0.083718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.014425', 'ticker_sentiment_score': '0.022535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.116333', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.010819', 'ticker_sentiment_score': '0.031519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOL', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.028174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.0984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNHI', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.09225', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADBE', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.027385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.056078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SONO', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.116333', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMAT', 'relevance_score': '0.010819', 'ticker_sentiment_score': '0.141612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.003607', 'ticker_sentiment_score': '-0.017149', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.057441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.098766', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.032316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.014425', 'ticker_sentiment_score': '0.127871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PPG', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.010201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLDR', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.028174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.014425', 'ticker_sentiment_score': '0.106253', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URI', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.074835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.021637', 'ticker_sentiment_score': '0.077273', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.051416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.014425', 'ticker_sentiment_score': '0.091194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.039655', 'ticker_sentiment_score': '0.085261', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.167311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNP', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.057441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.010201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.025241', 'ticker_sentiment_score': '0.133748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.003607', 'ticker_sentiment_score': '-0.017149', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.061298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.039655', 'ticker_sentiment_score': '0.114871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'USEG', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.039252', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICNB', 'relevance_score': '0.003607', 'ticker_sentiment_score': '0.177971', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VMC', 'relevance_score': '0.018031', 'ticker_sentiment_score': '0.07327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.014425', 'ticker_sentiment_score': '0.085763', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.007213', 'ticker_sentiment_score': '-0.057441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.010819', 'ticker_sentiment_score': '0.059346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.03245', 'ticker_sentiment_score': '0.0912', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.018031', 'ticker_sentiment_score': '0.025176', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.007213', 'ticker_sentiment_score': '0.078063', 'ticker_sentiment_label': 'Neutral'}]"
Cramer's week ahead: Keep an eye on banks as earnings season kicks off,https://www.cnbc.com/2023/10/13/cramers-week-ahead-keep-an-eye-on-banks-as-earnings-season-kicks-off.html,20231013T222151,['Julie Coleman'],"CNBC's Jim Cramer on Friday told investors what to look out for next week, with numerous major names reporting earnings.",https://image.cnbcfm.com/api/v1/image/106349607-1579721279110img_3326r.jpg?v=1697235711&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.050563,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.027333', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.097457', 'ticker_sentiment_score': '-0.095911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.111927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.021752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.171843', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.111927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.099194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.021752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.111927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.027333', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.099194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.171843', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.099194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.097457', 'ticker_sentiment_score': '-0.036334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KEY', 'relevance_score': '0.097457', 'ticker_sentiment_score': '0.099194', 'ticker_sentiment_label': 'Neutral'}]"
Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... - PR Newswire,https://www.prnewswire.com/news-releases/facial-serum-market-size-is-to-grow-by-usd-466-23-million-from-2022-to-2027--the-introduction-of-brands-owned-or-endorsed-by-celebrities-to-boost-market-growth---technavio-301955571.html,20231013T220000,[],Facial Serum Market size is to grow by USD 466.23 million from 2022 to 2027 | The introduction of brands owned or ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.280639,Somewhat-Bullish,"[{'ticker': 'BDRFF', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KAOCF', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSDOF', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COTY', 'relevance_score': '0.064623', 'ticker_sentiment_score': '0.117452', 'ticker_sentiment_label': 'Neutral'}]"
"Investing Action Plan: A Change Of Season As Netflix, Tesla Face Tests",https://www.investors.com/research/investing-action-plan/investing-action-plan-a-change-of-season-as-netflix-tesla-face-tests/,20231013T214500,"[""Investor's Business Daily"", 'IBD STAFF']","Investing Action Plan: A Change Of Season As Netflix, Tesla Face ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/09/Stock-fallleaves-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999701'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.08389,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.091597', 'ticker_sentiment_score': '0.091347', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.089595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANET', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.032889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.068764', 'ticker_sentiment_score': '0.033399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.17754', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GM', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.080844', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.022947', 'ticker_sentiment_score': '0.01108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.022947', 'ticker_sentiment_score': '-0.008963', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.016984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LVS', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.067379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.016984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NTES', 'relevance_score': '0.068764', 'ticker_sentiment_score': '0.033399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FITB', 'relevance_score': '0.045874', 'ticker_sentiment_score': '-0.009969', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.068764', 'ticker_sentiment_score': '0.033399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.020974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.137018', 'ticker_sentiment_score': '-0.034349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.091597', 'ticker_sentiment_score': '0.012766', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.016984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.123449', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.067704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.045874', 'ticker_sentiment_score': '-0.092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.032889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.045874', 'ticker_sentiment_score': '0.101496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STLD', 'relevance_score': '0.045874', 'ticker_sentiment_score': '-0.122362', 'ticker_sentiment_label': 'Neutral'}]"
"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets - United Airlines Holdings  ( NASDAQ:UAL ) , Johnson & Johnson  ( NYSE:JNJ ) , SLB  ( NYSE:SLB ) , Bank of New York Mellon  ( NYSE:BK ) ",https://www.benzinga.com/markets/equities/23/10/35248880/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets,20231013T203331,['Piero Cingari'],"Global geopolitical developments and domestic economic data shaped investor sentiment throughout the week, sparking fresh concerns regarding the outlook for growth and inflation. The week commenced with the eruption of conflict in the Middle East involving Israel and the Palestinian militant ...",https://cdn.benzinga.com/files/images/story/2023/Wall_Street_subway_sign_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.028703,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.047844', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLD', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ELV', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.047844', 'ticker_sentiment_score': '0.044356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'T', 'relevance_score': '0.047844', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.047844', 'ticker_sentiment_score': '0.060192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.047844', 'ticker_sentiment_score': '0.044356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.047127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Over Delivering: Big Banks Beat Expectations After Tough Quarter, but Market Eyes Middle East Warily - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/markets/23/10/35244544/over-delivering-big-banks-beat-expectations-after-tough-quarter-but-market-eyes-middle-east-warily,20231013T161933,['Schwab Network'],( Friday market open ) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety of fixed income. The benchmark 10-year U.S.,https://cdn.benzinga.com/files/images/story/2023/10/13/shutterstock_1388100275_5.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999855'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.014495,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.022185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.192842', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NTRS', 'relevance_score': '0.03786', 'ticker_sentiment_score': '-0.072356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.03786', 'ticker_sentiment_score': '-0.072356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.094464', 'ticker_sentiment_score': '0.120521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.050747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.032421', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.054847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TD', 'relevance_score': '0.11324', 'ticker_sentiment_score': '-0.034147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RF', 'relevance_score': '0.075635', 'ticker_sentiment_score': '-0.065115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.13564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.056763', 'ticker_sentiment_score': '-0.031996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.056763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.03786', 'ticker_sentiment_score': '-0.02637', 'ticker_sentiment_label': 'Neutral'}]"
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics,https://www.prnewswire.com/news-releases/growing-geriatric-population-fuels-ankylosing-spondylitis-market-management-of-pain-and-mobility-gains-importance-in-aging-demographics-301956060.html,20231013T154500,['Research and Markets'],Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance ... PR ...,https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.144187,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPMF', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.073209', 'ticker_sentiment_score': '0.139168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.073209', 'ticker_sentiment_score': '0.08925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.036643', 'ticker_sentiment_score': '0.067285', 'ticker_sentiment_label': 'Neutral'}]"
"J&J  ( JNJ )  to Report Q3 Earnings, Its First After Unit Spin-Off",https://www.zacks.com/stock/news/2165582/jj-jnj-to-report-q3-earnings-its-first-after-unit-spin-off,20231013T134900,['Zacks Equity Research'],J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.,https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.149943,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.130453', 'ticker_sentiment_score': '0.063321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.173333', 'ticker_sentiment_score': '-0.063835', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.257442', 'ticker_sentiment_score': '0.135924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.215702', 'ticker_sentiment_score': '0.094996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.080645', 'ticker_sentiment_label': 'Neutral'}]"
"UM Commerce Hosts Grand Opening of ""Marva's,"" Industry-First 360 Commerce Experience - PR Newswire",https://www.prnewswire.com/news-releases/um-commerce-hosts-grand-opening-of-marvas-industry-first-360-commerce-experience-301956034.html,20231013T110300,[],"UM Commerce Hosts Grand Opening of ""Marva's,"" Industry-First 360 Commerce Experience PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.257672,Somewhat-Bullish,"[{'ticker': 'SNEJF', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAT', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPRO', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.052226', 'ticker_sentiment_score': '0.187607', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... - PR Newswire",https://www.prnewswire.com/news-releases/ophthalmology-devices-market-size-to-grow-by-usd-19-93-billion-from-2022-to-2027--north-america-to-account-for-41-of-market-growth--technavio-301955503.html,20231013T083500,[],"Ophthalmology Devices Market size to grow by USD 19.93 billion from 2022 to 2027, North America to account for 41 ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.230614,Somewhat-Bullish,"[{'ticker': 'COO', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNSR', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESLOF', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STAA', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GKOS', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOCPF', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTLZF', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALC', 'relevance_score': '0.183895', 'ticker_sentiment_score': '0.172871', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IRIX', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHC', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TOPCF', 'relevance_score': '0.06179', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Take Five: War and peace of mind,https://www.reuters.com/business/take-five/global-markets-themes-graphic-pix-2023-10-13/,20231013T072000,['Reuters'],"LONDON Oct 13 ( Reuters ) - Geopolitics are at the forefront of everyone's minds after war broke out between Israel and Palestinian militant group Hamas, and the mood in markets is jittery at best.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/GGEZIRPNPNLVPNJHCXG4RG4UNY.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.016985,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMDUF', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.15788', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.09006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTRYF', 'relevance_score': '0.048425', 'ticker_sentiment_score': '-0.206922', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.048425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:PLN', 'relevance_score': '0.048425', 'ticker_sentiment_score': '-0.023059', 'ticker_sentiment_label': 'Neutral'}]"
Peering Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/10/35228760/peering-into-johnson-johnsons-recent-short-interest,20231012T194530,['Benzinga Insights'],"Johnson & Johnson's JNJ short percent of float has fallen 32.85% since its last report. The company recently reported that it has 22.26 million shares sold short, which is 0.92% of all regular shares that are available for trading.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.237013,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.081322', 'ticker_sentiment_label': 'Neutral'}]"
"Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc.  ( KVUE )  Investors and Encourages Investors to Contact the Firm Before December 8, 2023 - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/10/g35228334/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-kenv,20231012T192202,['Globe Newswire'],"NEW YORK, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.045664,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.692465', 'ticker_sentiment_score': '0.053559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.052379', 'ticker_sentiment_label': 'Neutral'}]"
Stellar Ventures and Cypress Growth Capital Commit to Fueling the Future of Robotics Software,https://www.prnewswire.com/news-releases/stellar-ventures-and-cypress-growth-capital-commit-to-fueling-the-future-of-robotics-software-301955366.html,20231012T183500,['PickNik Robotics'],"BOULDER, Colo., Oct. 12, 2023 /PRNewswire/ -- PickNik Robotics, ""The Unstructured Robotics Company,"" proudly announces a major milestone in its mission to bring robot arms out of factories and into our everyday lives.",https://mma.prnewswire.com/media/2245906/PICKNIK_ROBOTICS.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.432262,Bullish,"[{'ticker': 'SSNLF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.235082', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.235082', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AGTEF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.235082', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.235082', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"CPI Data Generates Calm Initial Reaction, But Some Troubling Trends Under the Surface - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/markets/23/10/35223366/cpi-data-generates-calm-initial-reaction-but-some-troubling-trends-under-the-surface,20231012T152601,['Schwab Center for Financial Research'],"( Thursday market open ) An eagerly awaited report on U.S. consumer inflation didn't appear too frightening early Thursday, and major indexes initially appeared unhindered as the October rally rolled on.",https://tickertapecdn.tdameritrade.com/assets/images/pages/md/chart-10-12.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.999989'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.02411,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.09158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.083251', 'ticker_sentiment_score': '0.062279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.083251', 'ticker_sentiment_score': '0.062279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.026632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.083251', 'ticker_sentiment_score': '0.062279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.026632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.041682', 'ticker_sentiment_score': '0.044686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.041682', 'ticker_sentiment_score': '-0.026632', 'ticker_sentiment_label': 'Neutral'}]"
Dow ETF in Focus Ahead of Q3 Earnings,https://www.zacks.com/stock/news/2165006/dow-etf-in-focus-ahead-of-q3-earnings,20231012T151000,['Sweta Killa'],"With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.",https://staticx-tuner.zacks.com/images/default_article_images/default161.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999174'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.108642,Neutral,"[{'ticker': 'DOW', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.016715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.180798', 'ticker_sentiment_score': '-0.00144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.055477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.180798', 'ticker_sentiment_score': '0.077339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.136113', 'ticker_sentiment_score': '-0.013245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.031511', 'ticker_sentiment_label': 'Neutral'}]"
JNJ: Johnson & Johnson  ( JNJ )  vs. Madrigal Pharmaceuticals  ( MDGL ) : Which Pharma Stock Is a Worthier October Investment?,https://stocknews.com/news/jnj-mdgl-johnson-johnson-jnj-vs-madrigal-pharmaceuticals-mdgl-which-pharma/,20231012T114952,['StockNews.com Staff'],JNJ: Johnson & Johnson ( JNJ ) vs. Madrigal Pharmaceuticals ... ...,https://stocknews.com/wp-content/uploads/2022/04/Vs.-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.99994'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999987'}]",0.197165,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.205032', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDGL', 'relevance_score': '0.417008', 'ticker_sentiment_score': '0.100708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.632922', 'ticker_sentiment_score': '0.16808', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future,https://www.fool.com/retirement/2023/10/12/medicare-recipients-could-see-lower-costs-for-thes/,20231012T091500,['Keith Speights'],Medicare will soon begin negotiations with drugmakers for the first time ever.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750108%2Folder-couple-pill-bottle.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.127947,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.08687', 'ticker_sentiment_score': '-0.129312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.08687', 'ticker_sentiment_score': '-0.129312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.08687', 'ticker_sentiment_score': '-0.129312', 'ticker_sentiment_label': 'Neutral'}]"
"Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida.",https://www.marketwatch.com/story/where-can-you-find-entertainment-beaches-jobs-low-cost-of-living-and-more-here-are-some-of-the-best-places-to-live-in-florida-2638454c,20231012T090200,['Livability'],"You're never far from the water, blue skies and sunshine in Florida. These cities offer thriving economies, low cost of living and a healthy active lifestyle.",https://images.mktw.net/im-425215?width=700&height=467,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.375762,Bullish,"[{'ticker': 'RDW', 'relevance_score': '0.029025', 'ticker_sentiment_score': '0.149857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.029025', 'ticker_sentiment_score': '0.184363', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DIS', 'relevance_score': '0.029025', 'ticker_sentiment_score': '0.007425', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029025', 'ticker_sentiment_score': '0.149857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSFE', 'relevance_score': '0.029025', 'ticker_sentiment_score': '0.149857', 'ticker_sentiment_label': 'Neutral'}]"
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04,https://www.globenewswire.com/news-release/2023/10/12/2758971/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html,20231012T080000,['Alvotech'],"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter ( CRL ) for Alvotech's Biologics License ...",https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.104414,Neutral,"[{'ticker': 'ALVO', 'relevance_score': '0.591955', 'ticker_sentiment_score': '0.153319', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TEVA', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.060316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMDA', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.060316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTUS', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.060316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.032211', 'ticker_sentiment_label': 'Neutral'}]"
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04,https://www.globenewswire.com/news-release/2023/10/12/2758972/0/en/Alvotech-Provides-Update-on-Status-of-U-S-Biologics-License-Application-for-AVT04.html,20231012T080000,['Alvotech'],"REYKJAVIK, Iceland, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration ( FDA ) has issued a complete ...",https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.111463,Neutral,"[{'ticker': 'ALVO', 'relevance_score': '0.586931', 'ticker_sentiment_score': '0.162845', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TEVA', 'relevance_score': '0.028388', 'ticker_sentiment_score': '0.060221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMDA', 'relevance_score': '0.028388', 'ticker_sentiment_score': '0.060221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LTUS', 'relevance_score': '0.028388', 'ticker_sentiment_score': '0.060221', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028388', 'ticker_sentiment_score': '0.125175', 'ticker_sentiment_label': 'Neutral'}]"
Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... - PR Newswire,https://www.prnewswire.com/news-releases/healthcare-education-solutions-market-size-to-grow-by-usd-5-30-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-3m-co-bbraun-se-and-becton-dickinson-and-co-and-many-more-301952875.html,20231011T231500,[],Healthcare Education Solutions Market size to grow by USD 5.30 billion from 2022 to 2027 | Market is fragmented due ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.327571,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.092834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAJFF', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMAWF', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRKR', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OCPNF', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHG', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BDX', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FUJIF', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.086725', 'ticker_sentiment_label': 'Neutral'}]"
Birkenstock slides about 10% in stock market debut after opening at $41 per share,https://www.cnbc.com/2023/10/11/birkenstock-ipo-birk-starts-trading-on-the-nyse.html,20231011T173411,['Gabrielle Fonrouge'],German shoe brand Birkenstock made its market debut Wednesday after pricing its IPO at $46.,https://image.cnbcfm.com/api/v1/image/107315226-1697034572902-gettyimages-1719128571-AFP_33XZ6ZE.jpeg?v=1697045651&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.18349,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.124486', 'ticker_sentiment_score': '0.117392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ODD', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.078193', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why You Should Invest in Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2164426/heres-why-you-should-invest-in-boston-scientific-bsx-now,20231011T144700,['Zacks Equity Research'],Investors are optimistic about Boston Scientific (BSX) on consistent growth and upbeat guidance.,https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99915'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.242473,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.070392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.070392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.070392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.293506', 'ticker_sentiment_score': '0.164302', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.070392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.070392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVA', 'relevance_score': '0.198221', 'ticker_sentiment_score': '0.077786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PXXXF', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.151212', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QTRX', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
The 20 companies engineering students around the world most want to work for,https://africa.businessinsider.com/careers/the-20-companies-engineering-students-around-the-world-most-want-to-work-for/yr5x4mp,20231011T140320,['Madison Hoff'],"That's based on the World's Most Attractive Employers report for this year from employer-branding company Universum. The newly published engineering-student ranking from the report, along with the other global rankings part of it, are based on how students of different college and university ...",https://ocdn.eu/pulscms-transforms/1/hNJktkuTURBXy9iZTgxOGRmMy1jYjllLTQ5Y2YtYjNjYy05Y2UyYjk2NTUwMDkuanBlZ5GTBc0DFs0Brg,Business Insider,GoogleRSS,africa.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.171211,Somewhat-Bullish,"[{'ticker': 'BA', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.106751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.106751', 'ticker_sentiment_label': 'Neutral'}]"
The 20 companies engineering students around the world most want to work for,https://www.businessinsider.com/companies-engineering-students-around-world-want-to-work-for-2023-10,20231011T140300,['Madison Hoff'],Companies engineering students around the world want to work for - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.229597,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.439345', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.543004', 'ticker_sentiment_score': '0.473985', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.17187', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.380012', 'ticker_sentiment_score': '0.226527', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.075947', 'ticker_sentiment_label': 'Neutral'}]"
2 No-Brainer Dividend King Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/11/2-no-brainer-dividend-king-stocks-to-buy-right-now/,20231011T124500,['George Budwell'],These two blue-chip stocks should hold up well in a choppy market.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750416%2Ftime-to-buy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.383773,Bullish,"[{'ticker': 'KO', 'relevance_score': '0.319725', 'ticker_sentiment_score': '0.356695', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.282736', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.207583', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Delaware Investments Mutual Funds for Solid Returns,https://www.zacks.com/stock/news/2164054/3-delaware-investments-mutual-funds-for-solid-returns,20231011T090900,['Zacks Equity Research'],"Invest in Delaware Investments mutual funds such as WLGYX, IDAAX and DDFAX for the opportunity to maximize your investment returns.",https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999967'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.294286,Somewhat-Bullish,"[{'ticker': 'MCQEF', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.248564', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XM', 'relevance_score': '0.069094', 'ticker_sentiment_score': '-0.01612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HES', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( NYSE:JNJ )  Upgraded by StockNews.com to Strong-Buy,https://www.defenseworld.net/2023/10/11/johnson-johnson-nysejnj-upgraded-by-stocknews-com-to-strong-buy.html,20231011T080244,['Defense World Staff'],Johnson & Johnson ( NYSE:JNJ ) Upgraded by StockNews.com to ... Defense World ...,https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.846708'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.30983,Somewhat-Bullish,"[{'ticker': 'MS', 'relevance_score': '0.040829', 'ticker_sentiment_score': '0.093661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.040829', 'ticker_sentiment_score': '0.094895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.717663', 'ticker_sentiment_score': '0.495744', 'ticker_sentiment_label': 'Bullish'}]"
"Sinus Dilation Devices Market Revenue to Cross USD 4.7 billion in 2031, Securing a 7.2% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/10/g35183414/sinus-dilation-devices-market-revenue-to-cross-usd-4-7-billion-in-2031-securing-a-7-2-cagr-says-tr,20231011T072554,['Globe Newswire'],"Wilmington, Delaware, United States, Oct. 11, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global sinus dilation devices market is anticipated to expand at a 7.2% CAGR from 2021 to 2031. The market for sinus dilation devices is expected to reach US$ 4.7 billion by 2031.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.294154,Somewhat-Bullish,"[{'ticker': 'SNN', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.049951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.09324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OCPNF', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.049951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.049951', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.049951', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson Upgraded to ""Strong-Buy"" Rating by StockNews.com",https://www.claytoncountyregister.com/news2/johnson-johnson-nysejnj-stock-rating-upgraded-by-stocknews-com/564546/,20231011T051209,['Barret Loux'],"Johnson & Johnson Upgraded to ""Strong-Buy"" Rating by StockNews ... Clayton County Register ...",https://www.claytoncountyregister.com/wp-content/uploads/2023/07/mfrack_realistic_photo_of_German_stock_exchange_fd73ce83-c418-4c01-83ae-070526825e8c.jpeg,Stocknews.com,n/a,www.claytoncountyregister.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.263318,Somewhat-Bullish,"[{'ticker': 'WFC', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.059481', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.870696', 'ticker_sentiment_score': '0.434441', 'ticker_sentiment_label': 'Bullish'}]"
"Birkenstock expects to price IPO at $46 per share, toward midpoint of stated range",https://www.cnbc.com/2023/10/10/birkenstock-expects-to-price-ipo-at-46-per-share.html,20231010T205939,"['Leslie Picker', 'Gabrielle Fonrouge']",German shoemaker Birkenstock is expected to price its IPO at $46 per share on Tuesday.,https://image.cnbcfm.com/api/v1/image/107300018-1694612492332-gettyimages-1662222510-20090101230913-99-179166.jpeg?v=1696971579&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.214548,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.185764', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ODD', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.185764', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.004316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.185764', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35170396/johnson-johnson-unusual-options-activity,20231010T200053,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.113402,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.749166', 'ticker_sentiment_score': '0.279992', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"As Middle East Conflict Continues, Yields Recede, Giving Stocks A Light Tailwind - Citigroup  ( NYSE:C ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/markets/23/10/35168047/as-middle-east-conflict-continues-yields-recede-giving-stocks-a-light-tailwind,20231010T172106,['Schwab Center for Financial Research'],"( Tuesday market open ) Back from their three-day holiday weekend, U.S. Treasury note yields slipped early Tuesday, initially providing traction for stocks in premarket trading before the market flattened ahead of the open.",https://cdn.benzinga.com/files/images/story/2023/10/10/shutterstock_1928985866_7.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '1.0'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999756'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.028985,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.042159', 'ticker_sentiment_score': '0.088752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DMPZF', 'relevance_score': '0.021087', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.042159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.042159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.084201', 'ticker_sentiment_score': '0.039851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.084201', 'ticker_sentiment_score': '0.039851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.084201', 'ticker_sentiment_score': '0.039851', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.084201', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.021087', 'ticker_sentiment_score': '0.066519', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.042159', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.063202', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.021087', 'ticker_sentiment_score': '0.034554', 'ticker_sentiment_label': 'Neutral'}]"
Earnings Preview: Johnson & Johnson  ( JNJ )  Q3 Earnings Expected to Decline,https://www.zacks.com/stock/news/2163470/earnings-preview-johnson-johnson-jnj-q3-earnings-expected-to-decline,20231010T140016,['Zacks Equity Research'],Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default258.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.15492,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.295273', 'ticker_sentiment_score': '0.083135', 'ticker_sentiment_label': 'Neutral'}]"
"Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of ""Next Generation Director"" Development Program",https://www.prnewswire.com/news-releases/russell-reynolds-associates-world-50-group-to-help-accelerate-executive-diversity-with-third-cohort-of-next-generation-director-development-program-301951425.html,20231010T130000,['Russell Reynolds Associates'],"Russell Reynolds Associates, World 50 Group To Help Accelerate Executive Diversity With Third Cohort of ""Next ... PR ...",https://mma.prnewswire.com/media/1502546/Russell_Reynolds_Associates_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.37705,Bullish,"[{'ticker': 'SYF', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.217634', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATGE', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.217634', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.04161', 'ticker_sentiment_score': '0.089247', 'ticker_sentiment_label': 'Neutral'}]"
Society Pass Inc.  ( Nasdaq: SOPA )  Announces Plans to Spinout Two Profitable Business Units Into New Publicly-Traded Companies via Nasdaq IPOs in 2024,https://www.globenewswire.com/news-release/2023/10/10/2757479/0/en/Society-Pass-Inc-Nasdaq-SOPA-Announces-Plans-to-Spinout-Two-Profitable-Business-Units-Into-New-Publicly-Traded-Companies-via-Nasdaq-IPOs-in-2024.html,20231010T123000,['Society Pass Incorporated'],"NEW YORK, NY, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Society Pass Inc. ( Nasdaq: SOPA ) ( ""SoPa"" or the ""Company"" ) , Southeast Asia's ( ""SEA"" ) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, announces that its Board of Directors, together with its ...",https://ml.globenewswire.com/Resource/Download/af90c8eb-2176-4e65-8a4f-07e034f597c2,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.274762,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.086245', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057559', 'ticker_sentiment_score': '0.070955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SOPA', 'relevance_score': '0.361155', 'ticker_sentiment_score': '0.326541', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc.",https://www.benzinga.com/pressreleases/23/10/g35160236/ibn-announces-latest-episode-of-the-bell2bell-podcast-featuring-rob-etherington-ceo-of-clene-inc,20231010T121700,['Globe Newswire'],"LOS ANGELES, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.202221,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.020297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLNN', 'relevance_score': '0.307661', 'ticker_sentiment_score': '0.225737', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.182241', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.182241', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2163168/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,20231010T102006,['Zacks Equity Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.304478,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.049458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.049458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.049458', 'ticker_sentiment_label': 'Neutral'}]"
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2163169/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,20231010T102005,['Zacks Equity Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.150003,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.031033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.063692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZTS', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.063692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.043293', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.132004', 'ticker_sentiment_score': '0.063692', 'ticker_sentiment_label': 'Neutral'}]"
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2163163/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,20231010T102005,['Zacks Equity Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.233966,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.117025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.195175', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.068464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.068464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.122894', 'ticker_sentiment_score': '0.068464', 'ticker_sentiment_label': 'Neutral'}]"
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2163174/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,20231010T102005,['Zacks Equity Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.236793,Somewhat-Bullish,"[{'ticker': 'JPM', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.061185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.061185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.061185', 'ticker_sentiment_label': 'Neutral'}]"
"Shake it off: Travis Kelce hip to Taylor Swift's lyrics as he slips free from injury, Rodgers insult",https://apnews.com/article/behind-call-kelce-rodgers-2f0725e098511f88ba36a25faa760503,20231010T100000,['ARNIE MELENDREZ STAPLETON'],"Need another sign that Travis Kelce and Taylor Swift are simply meant to be together or ""Tayvis"" or besties or whatever it is they are? How about this: the Kansas City Chiefs star tight end just spent Week 5 dealing with both a gnarly-looking sprained ankle and a needless dig from Aaron Rodgers ...",https://dims.apnews.com/dims4/default/c9c4193/2147483647/strip/true/crop/7473x4978+0+2/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F7f%2F0a%2F5352319e1e6c19cd6fb6af628443%2Fd0c856f80c944957bd8293347447989d,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.114076,Neutral,"[{'ticker': 'PFE', 'relevance_score': '0.296463', 'ticker_sentiment_score': '0.167273', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.027953', 'ticker_sentiment_label': 'Neutral'}]"
New Equity Research Report Recommends 'Buy' Rating for Virtualware  ( EPA:MLVIR )  with €10 Price Target,https://www.globenewswire.com/news-release/2023/10/10/2757117/0/en/New-Equity-Research-Report-Recommends-Buy-Rating-for-Virtualware-EPA-MLVIR-with-10-Price-Target.html,20231010T054500,['VIRTUALWARE 2007 SA'],"New York and Bilbao, Spain, 10, October.- Litchfield Hills Research initiated coverage of Virtualware ( ENXTPA: MLVIR ) with a 'Buy' rating and €10 ( $10.56 ) price target, according to an equity research report published and distributed Monday.",https://ml-eu.globenewswire.com/Resource/Download/13948b91-ce96-426f-b8a7-b1586665fb52,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.178587,Somewhat-Bullish,"[{'ticker': 'HTHIF', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.097811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBDSF', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.097811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOMFF', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.097811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.097811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.097811', 'ticker_sentiment_label': 'Neutral'}]"
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,20231009T210100,"['LLP', 'DelveInsight Business Research']","The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand ... PR ...",https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.009725,Neutral,"[{'ticker': 'BGNE', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.026267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLUE', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.036038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.033442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RSSS', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.124364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.036038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONS', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.029703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.029364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.034129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.032874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACLX', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.026267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AGIO', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.029703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLN', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.029703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRTHF', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.026267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPN', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.033264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.033264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIGL', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.033264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.029364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCCC', 'relevance_score': '0.018173', 'ticker_sentiment_score': '0.026267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.036338', 'ticker_sentiment_score': '0.047119', 'ticker_sentiment_label': 'Neutral'}]"
Penny Stocks To Buy This Week? Analysts Like These 3,https://pennystocks.com/featured/2023/10/09/penny-stocks-to-buy-this-week-analysts-like-these-3/,20231009T200608,['J. Samuel'],"Penny Stocks: Using Analyst Sentiment and Research for Smart Trading Penny stocks are shares of small companies priced under $5 per share. While the potential returns can be alluring, penny stocks carry high risk. Thorough research is essential before trading.",,PennyStocks.com,n/a,pennystocks.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.138709,Neutral,"[{'ticker': 'MXCT', 'relevance_score': '0.125297', 'ticker_sentiment_score': '-0.013114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCLX', 'relevance_score': '0.156258', 'ticker_sentiment_score': '0.00943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.031446', 'ticker_sentiment_score': '-0.001896', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.031446', 'ticker_sentiment_score': '-0.001896', 'ticker_sentiment_label': 'Neutral'}]"
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/10/35150435/looking-at-johnson-johnsons-recent-unusual-options-activity,20231009T190114,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with ...",https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.137597,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.677342', 'ticker_sentiment_score': '0.056099', 'ticker_sentiment_label': 'Neutral'}]"
J&J  ( JNJ )  Seeks EU Nod for Rybrevant for First-Line NSCLC,https://www.zacks.com/stock/news/2162746/jj-jnj-seeks-eu-nod-for-rybrevant-for-first-line-nsclc,20231009T151000,['Zacks Equity Research'],J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.,https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.231883,Somewhat-Bullish,"[{'ticker': 'CORT', 'relevance_score': '0.124486', 'ticker_sentiment_score': '0.060792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AUPH', 'relevance_score': '0.304679', 'ticker_sentiment_score': '0.234426', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALPN', 'relevance_score': '0.245959', 'ticker_sentiment_score': '0.195126', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.245959', 'ticker_sentiment_score': '-0.059285', 'ticker_sentiment_label': 'Neutral'}]"
Janssen Highlights Latest Research for TREMFYA®  ( guselkumab )  and Investigational Targeted Oral Peptide JNJ-2113 in Moderate to Severe Plaque Psoriasis at the European Academy of Dermatology and Venereology  ( EADV )  Congress,https://www.prnewswire.com/news-releases/janssen-highlights-latest-research-for-tremfya-guselkumab-and-investigational-targeted-oral-peptide-jnj-2113-in-moderate-to-severe-plaque-psoriasis-at-the-european-academy-of-dermatology-and-venereology-eadv-congress-301949936.html,20231009T113100,['Janssen Pharmaceutical Companies of Johnson & Johnson'],Janssen Highlights Latest Research for TREMFYA® ( guselkumab ) and Investigational Targeted Oral Peptide JNJ-2113 ... PR ...,https://mma.prnewswire.com/media/1006365/Janssen_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.007263,Neutral,"[{'ticker': 'PTGX', 'relevance_score': '0.17991', 'ticker_sentiment_score': '0.123068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.335845', 'ticker_sentiment_score': '0.046641', 'ticker_sentiment_label': 'Neutral'}]"
Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On,https://www.fool.com/investing/2023/10/09/3-dividend-kings-warren-buffett-bet-21-billion-on/,20231009T092100,['Sean Williams'],Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750048%2Fbuffett6-tmf.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.275186,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.031654', 'ticker_sentiment_score': '-0.02116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.337532', 'ticker_sentiment_score': '0.294014', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.031654', 'ticker_sentiment_score': '0.055431', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.031654', 'ticker_sentiment_score': '0.155834', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.157278', 'ticker_sentiment_score': '0.22646', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.157278', 'ticker_sentiment_score': '0.119051', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.031654', 'ticker_sentiment_score': '0.188243', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder,https://markets.businessinsider.com/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618,20231008T171842,['markets.businessinsider.com'],( RTTNews ) - The new safety data from the ESCAPE-TRD Phase 3b study suggested Johnson & Johnson's Spravato or esketamine nasal spray was more tolerable and effective compared to quetiapine extended-release in adults with treatment-resistant major depressive disorder.,https://markets.businessinsider.com/Images/FacebookIcon.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.024008,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.181137', 'ticker_sentiment_score': '-0.143264', 'ticker_sentiment_label': 'Neutral'}]"
My Top Under-Appreciated Dividend King to Buy in October,https://www.fool.com/investing/2023/10/08/my-top-under-appreciated-dividend-king-buy-october/,20231008T095700,['Daniel Foelber'],This company is putting on a clinic on how to operate as a successful industrial conglomerate.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749872%2Fsparks-fly-off-of-a-circular-saw-in-a-factory.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}]",0.307932,Somewhat-Bullish,"[{'ticker': 'YUM', 'relevance_score': '0.117295', 'ticker_sentiment_score': '0.081526', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.094794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.136068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.094794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.094794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSBHF', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.136068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.040328', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITW', 'relevance_score': '0.508878', 'ticker_sentiment_score': '0.458503', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GE', 'relevance_score': '0.039224', 'ticker_sentiment_score': '0.136068', 'ticker_sentiment_label': 'Neutral'}]"
Could The Next Tech Unicorn Be Hiding In A Forest Of Patents?,https://www.forbes.com/sites/carolynschwaar/2023/10/07/could-the-next-tech-unicorn-be-hiding-in-a-forest-of-patents/,20231007T134346,['Carolyn Schwaar'],"As 3D printing continues to evolve as a manufacturing method, patent data provides valuable insight into the technological landscape and areas of innovation.","https://imageio.forbes.com/specials-images/imageserve/652157ad6369b876ad4a1fce/0x0.jpg?format=jpg&crop=2048,1153,x0,y101,safe&width=1200",Forbes,Business,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.169928,Somewhat-Bullish,"[{'ticker': 'ADSK', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.148082', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.049634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DM', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.049634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SINT', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.060235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MKFG', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.049634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSYS', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.049634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.049634', 'ticker_sentiment_label': 'Neutral'}]"
"Malinda Williams, Founder of The Arise And Shine Women's Empowerment Brunch, celebrated 5 years of uplifting, uniting and inspiring black women",https://www.benzinga.com/pressreleases/23/10/n35134983/malinda-williams-founder-of-the-arise-and-shine-womens-empowerment-brunch-celebrated-5-years-of-up,20231007T004500,['PRNewswire'],"Williams also announced the launch of the Arise And Shine Foundation, a 501 ( c ) ( 3 ) that aims to advance the professional development of underserved and underrepresented women and girls. The E.S.T.E.A.M Project will be the pilot program under the new nonprofit.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.530581,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.044634', 'ticker_sentiment_score': '0.267963', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Kansas City Chiefs' Travis Kelce laughs off Aaron Rodgers' 'Mr. Pfizer' quip,https://www.cnn.com/2023/10/06/sport/travis-kelce-aaron-rodgers-nickname-swift-spt-intl/index.html,20231006T215800,['Jacob Lev'],"Travis Kelce has laughed off Aaron Rodgers' new nickname for the Kansas City Chiefs tight end after the injured New York Jets quarterback called him ""Mr. Pfizer"" during his weekly appearance on ESPN's ""The Pat McAfee Show.""","https://media.cnn.com/api/v1/images/stellar/prod/231005140840-05-taylor-swift-travis-kelce-split.jpg?c=16x9&q=h_720,w_1280,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.315412,Somewhat-Bullish,"[{'ticker': 'MET', 'relevance_score': '0.07423', 'ticker_sentiment_score': '-0.015248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.485711', 'ticker_sentiment_score': '0.38099', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.147818', 'ticker_sentiment_score': '-0.080342', 'ticker_sentiment_label': 'Neutral'}]"
The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... - PR Newswire,https://www.prnewswire.com/news-releases/the-executive-leadership-councils-symposium-and-recognition-gala-week-wraps-up-with-1m-community-impact-investment-301949944.html,20231006T204000,[],The Executive Leadership Council's Symposium and Recognition Gala Week Wraps Up with $1M Community Impact ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.322297,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.142565', 'ticker_sentiment_score': '0.130674', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HPQ', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.055272', 'ticker_sentiment_label': 'Neutral'}]"
Will Johnson & Johnson  ( JNJ )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2161719/will-johnson-johnson-jnj-beat-estimates-again-in-its-next-earnings-report,20231006T161011,['Zacks Equity Research'],Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,https://staticx-tuner.zacks.com/images/default_article_images/default304.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.327439,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.396261', 'ticker_sentiment_score': '0.474656', 'ticker_sentiment_label': 'Bullish'}]"
"Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35111380/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bulli,20231005T164011,['Priya Nigam'],"Shares of Johnson & Johnson JNJ recovered slightly in early trading on Thursday, after tanking in the previous session. The company is ""uniquely positioned with Pharma and MedTech under one umbrella,"" according to RBC Capital Markets.",https://cdn.benzinga.com/files/images/story/2023/10/05/johnsonandjohnson.turbaliska.shutterstock_1403911202.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.192158,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.973732', 'ticker_sentiment_score': '0.286539', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Stocks making the biggest moves midday: Rivian, Orchard Therapeutics, Lamb Weston and more",https://www.cnbc.com/2023/10/05/stocks-making-the-biggest-moves-midday-rivian-orchard-therapeutics-lamb-weston-and-more.html,20231005T163426,['Lisa Kailai Han'],These are the stocks posting the largest moves in midday trading.,https://image.cnbcfm.com/api/v1/image/101253784-142606586r.jpg?v=1696523666&w=1920&h=1080,CNBC,Market Insider,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.189709,Somewhat-Bullish,"[{'ticker': 'CARR', 'relevance_score': '0.060848', 'ticker_sentiment_score': '-0.124407', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORTX', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.087002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.060848', 'ticker_sentiment_score': '-0.124407', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.192338', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.01708', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.120012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.043871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KNBWF', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.087002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LW', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.22248', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLX', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.186009', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARMK', 'relevance_score': '0.060848', 'ticker_sentiment_score': '-0.003034', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.060848', 'ticker_sentiment_score': '-0.141731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.120012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STZ', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.06409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KYKOF', 'relevance_score': '0.060848', 'ticker_sentiment_score': '0.087002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LOB', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.02017', 'ticker_sentiment_label': 'Neutral'}]"
3 Ways AI Can Help Healthcare Companies Grow,https://www.fool.com/investing/2023/10/05/3-ways-ai-can-help-healthcare-companies-grow/,20231005T120000,['David Jagielski'],"The hottest AI stocks are in tech right now, but the best opportunities ahead may be in healthcare.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.357144,Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.154785', 'ticker_sentiment_score': '0.204034', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TDOC', 'relevance_score': '0.103554', 'ticker_sentiment_score': '0.121281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.20537', 'ticker_sentiment_score': '0.312891', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.051886', 'ticker_sentiment_score': '0.185956', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.154785', 'ticker_sentiment_score': '0.16921', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 Magnificent Dividend Kings to Buy Now,https://www.fool.com/investing/2023/10/05/2-magnificent-dividend-kings-to-buy-now/,20231005T100000,['Adria Cimino'],These stocks offer you income no matter what the market is doing.,https://media.ycharts.com/charts/49cee2af8a8aa6734c4be7160841217f.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.997405'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.99246'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.335081,Somewhat-Bullish,"[{'ticker': 'KO', 'relevance_score': '0.362505', 'ticker_sentiment_score': '0.427652', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KVUE', 'relevance_score': '0.062597', 'ticker_sentiment_score': '-0.02804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.124809', 'ticker_sentiment_score': '-0.032715', 'ticker_sentiment_label': 'Neutral'}]"
"Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease",https://www.globenewswire.com/news-release/2023/10/05/2755164/0/en/Phase-III-studies-to-investigate-survodutide-for-people-living-with-obesity-and-overweight-with-and-without-diabetes-cardiovascular-disease-and-chronic-kidney-disease.html,20231005T095300,['Zealand Pharma'],"Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease • SYNCHRONIZE-1 and SYNCHRONIZE-2 are global Phase III studies of survodutide ( BI 456906 ) in people living with obesity and ...",https://ml-eu.globenewswire.com/Resource/Download/8e5dac9c-86c4-4996-bce9-0f8ba208f970,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.026403,Neutral,"[{'ticker': 'HLF', 'relevance_score': '0.027164', 'ticker_sentiment_score': '0.05734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.027164', 'ticker_sentiment_score': '0.05734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027164', 'ticker_sentiment_score': '0.05734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZLDPF', 'relevance_score': '0.054297', 'ticker_sentiment_score': '0.086994', 'ticker_sentiment_label': 'Neutral'}]"
3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October,https://www.fool.com/investing/2023/10/05/3-historically-cheap-dow-stocks-to-buy-in-october/,20231005T092100,['Sean Williams'],"These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749618%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999996'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.141321,Neutral,"[{'ticker': 'SPGI', 'relevance_score': '0.031654', 'ticker_sentiment_score': '0.223138', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VZ', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.033183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.126119', 'ticker_sentiment_score': '0.086394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.188193', 'ticker_sentiment_score': '0.20772', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBA', 'relevance_score': '0.094762', 'ticker_sentiment_score': '-0.067757', 'ticker_sentiment_label': 'Neutral'}]"
India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... - PR Newswire,https://www.prnewswire.com/news-releases/india-baby-care-products-market-size-to-grow-by-usd-15-69-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-artsana-spa-bio-veda-action-research-co-and-many-mo-301944281.html,20231004T230000,[],India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.287139,Somewhat-Bullish,"[{'ticker': 'KMB', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MHCRF', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PIGEF', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHG', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.089055', 'ticker_sentiment_label': 'Neutral'}]"
Promaxo Receives Direct Investment from Surgical Robotics Industry Pioneer Fred Moll and Announces Appointment as Strategic Advisor,https://www.benzinga.com/pressreleases/23/10/g35092941/promaxo-receives-direct-investment-from-surgical-robotics-industry-pioneer-fred-moll-and-announces,20231004T160000,['Globe Newswire'],"OAKLAND, Calif., Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Promaxo, Inc. ( ""Promaxo"" or the ""Company"" ) , a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.229312,Somewhat-Bullish,"[{'ticker': 'ISRG', 'relevance_score': '0.172713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRCT', 'relevance_score': '0.172713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.172713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.172713', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market Research",https://www.prnewswire.com/news-releases/medical-supplies-market-size-is-projected-to-hit-usd-185-21-billion-at-a-4-5-cagr-by-2028--brandessence-market-research-301947208.html,20231004T151500,['Brandessence Market Research and Consulting Private Limited'],"Medical Supplies Market Size is Projected to Hit USD 185.21 Billion, at a 4.5% CAGR by 2028 | Brandessence Market ... PR ...",https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.28991,Somewhat-Bullish,"[{'ticker': 'LXRX', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.251231', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INVA', 'relevance_score': '0.067536', 'ticker_sentiment_score': '0.167595', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TMO', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAX', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MDT', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MMM', 'relevance_score': '0.067536', 'ticker_sentiment_score': '-0.16357', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Showpad Recognized as a Leader in Sales Readiness Solutions,https://www.benzinga.com/pressreleases/23/10/g35091831/showpad-recognized-as-a-leader-in-sales-readiness-solutions,20231004T150509,['Globe Newswire'],"Top-tier industry analyst firm recognizes Showpad as it:""paves the way with a comprehensive solution and a focused market approach"" CHICAGO, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Showpad, a global leader in sales enablement, has secured a coveted spot as a recognized leader in The Forrester Wave™: ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.438513,Bullish,"[{'ticker': 'CCEP', 'relevance_score': '0.058759', 'ticker_sentiment_score': '0.068072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.058759', 'ticker_sentiment_score': '0.068072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058759', 'ticker_sentiment_score': '0.068072', 'ticker_sentiment_label': 'Neutral'}]"
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/10/04/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday.html,20231004T131212,['Jim Cramer'],"Stock futures are up on light jobs data, but several headwinds keeping a lid on prices.",https://image.cnbcfm.com/api/v1/image/107306729-16957419172023-09-26t152140z_1602763426_rc2eg3a3yuvw_rtrmadp_0_usa-stocks.jpeg?v=1696425132&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.997902'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.019354,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.122269', 'ticker_sentiment_score': '0.131755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.163269', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.299478', 'ticker_sentiment_score': '-0.223117', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HAL', 'relevance_score': '0.122269', 'ticker_sentiment_score': '0.135998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.048044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.11', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.299478', 'ticker_sentiment_score': '0.146776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.061315', 'ticker_sentiment_score': '-0.058223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.06858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.06858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.061315', 'ticker_sentiment_score': '-0.13571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SQ', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.199354', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2159912/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,20231004T130010,['Zacks Equity Research'],"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.235541,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.475838', 'ticker_sentiment_score': '0.129986', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why Kenvue Stock Is  ( Slightly )  Riskier Than It Seems,https://www.fool.com/investing/2023/10/04/heres-why-kenvue-stock-is-slightly-riskier-than-it/,20231004T123600,['Alex Carchidi'],"It's not about to crash, but eventually, it might struggle to thrive.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",0.087268,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.431371', 'ticker_sentiment_score': '0.149313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.056808', 'ticker_sentiment_score': '0.14301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.056808', 'ticker_sentiment_score': '0.14301', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.056808', 'ticker_sentiment_score': '0.006', 'ticker_sentiment_label': 'Neutral'}]"
"Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... - PR Newswire",https://www.prnewswire.com/news-releases/esteemed-leader-robert-pemberton-joins-forces-with-co-founders-anthony-uzzo-and-jim-gregory-to-accelerate-service-insights-path-to-enable-digital-transformation-across-diverse-industries-301946103.html,20231004T120000,[],"Esteemed Leader, Robert Pemberton, Joins Forces with Co-Founders Anthony Uzzo and Jim Gregory to Accelerate ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.564212,Bullish,"[{'ticker': 'ISRG', 'relevance_score': '0.045396', 'ticker_sentiment_score': '0.256005', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AGTEF', 'relevance_score': '0.045396', 'ticker_sentiment_score': '0.172068', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.045396', 'ticker_sentiment_score': '0.256005', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"You Can't Control Recessions, but You Can Control What You Do About Them",https://www.fool.com/investing/2023/10/04/you-cant-control-recessions-but-you-can-control-wh/,20231004T093200,['Marc Rapport'],These strategies can help you weather the storms to come ... and they will come.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749556%2Frecession-fear-economy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99737'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.132831,Neutral,"[{'ticker': 'DG', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.160979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NEM', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.358117', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'PG', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.160979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GTY', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.06003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.160979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.160979', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ED', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.094943', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.06003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Global South should learn from Big Pharma's bullying of South Africa,https://www.aljazeera.com/opinions/2023/10/4/global-south-should-learn-from-big-pharmas-bullying-of-south-africa,20231004T084241,['Ray Mwareya'],The extortionate vaccine contracts Pretoria signed during the pandemic demonstrate why achieving pharmaceutical sovereignty should be a priority for all developing nations.,https://www.aljazeera.com/wp-content/uploads/2021/12/2021-12-16T185808Z_56729251_RC2UFR99D011_RTRMADP_3_TRADE-WTO.jpg?resize=770%2C513&quality=80,Al Jareeza,n/a,www.aljazeera.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.058231,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.03798', 'ticker_sentiment_score': '-0.007817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.075874', 'ticker_sentiment_score': '-0.004109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.03798', 'ticker_sentiment_score': '-0.007817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.000994', 'ticker_sentiment_label': 'Neutral'}]"
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration,20231003T173519,['Vandana Singh'],"All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.",https://cdn.benzinga.com/files/images/story/2023/10/03/pills-image_by_steve_buissinne_from_pixabay.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.08438,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Drugmakers Agree To US Govt Price Talks Amid Pushback,https://www.barrons.com/news/drugmakers-agree-to-us-govt-price-talks-amid-pushback-c7eb4567,20231003T154800,['Beiyi SEOW'],Drugmakers Agree To US Govt Price Talks Amid ...,https://www.barrons.com/asset/external-media/afp/AFP2007430630409481451714611589397832456678---1.jpg,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.048405,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.148076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.070725', 'ticker_sentiment_score': '-0.235822', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.070725', 'ticker_sentiment_score': '-0.029698', 'ticker_sentiment_label': 'Neutral'}]"
Court tosses $223.8 million verdict against J&J in talc cancer case,https://www.reuters.com/markets/us/court-tosses-2238-million-verdict-against-jj-talc-cancer-case-2023-10-03/,20231003T145700,['Brendan Pierson'],Oct 3 ( Reuters ) - A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson ( JNJ.N ) that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.,https://s3.amazonaws.com/arc-authors/reuters/75c45489-f2d2-466a-9429-aeeb9ef3b6f1.png,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.155816,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.032967', 'ticker_sentiment_label': 'Neutral'}]"
Sanofi  ( SNY )  Inks Deal With J&J to Develop E. coli Vaccine,https://www.zacks.com/stock/news/2159363/sanofi-sny-inks-deal-with-jj-to-develop-e-coli-vaccine,20231003T144500,['Zacks Equity Research'],"Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.",https://staticx-tuner.zacks.com/images/articles/main/8d/2080.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.126213,Neutral,"[{'ticker': 'VAXX', 'relevance_score': '0.229149', 'ticker_sentiment_score': '0.08764', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANVS', 'relevance_score': '0.229149', 'ticker_sentiment_score': '0.048782', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.220831', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.562664', 'ticker_sentiment_score': '0.304949', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Top Stories Tuesday, Oct 3: 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals - Apple  ( NASDAQ:AAPL ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",https://www.benzinga.com/news/23/10/35064552/airbnb-has-foundational-cracks-disney-follows-netflix-on-subscription-sharing-crackdown-microsofts-n,20231003T141120,['Vandana Singh'],"In a significant development, Microsoft Corp's MSFT CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence ( AI ) .",https://cdn.benzinga.com/files/images/story/2023/10/03/airbnbtoronto5.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.058194,Neutral,"[{'ticker': 'TGT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.263048', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.189076', 'ticker_sentiment_score': '0.273786', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.038162', 'ticker_sentiment_score': '0.139139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPOT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.144617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.21709', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.067693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.143767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.017859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.098084', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASML', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.14478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.038103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNT', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.179376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VTRS', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.067102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.179376', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALXO', 'relevance_score': '0.076236', 'ticker_sentiment_score': '-0.146817', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GME', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.130984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.021659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.114137', 'ticker_sentiment_score': '-0.064201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.076236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NXC', 'relevance_score': '0.038162', 'ticker_sentiment_score': '-0.036553', 'ticker_sentiment_label': 'Neutral'}]"
3 Healthcare Stocks to Keep an Eye On,https://www.fool.com/investing/2023/10/03/3-healthcare-stocks-to-keep-an-eye-on/,20231003T134500,['Jim Halley'],These three lesser-known healthcare companies have strong growth potential.,https://media.ycharts.com/charts/708f4f4146d09672fb407e1bdf85ea69.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.17539,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.146304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TECH', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.222992', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNA', 'relevance_score': '0.198384', 'ticker_sentiment_score': '0.165547', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSUMF', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SOMMF', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.040078', 'ticker_sentiment_score': '0.02641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.157705', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine - Johnson & Johnson  ( NYSE:JNJ ) , Sanofi  ( NASDAQ:SNY ) ",https://www.benzinga.com/general/biotech/23/10/35054080/pharma-giants-sanofi-johnson-johnson-join-forces-to-develop-e-coli-vaccine,20231003T122542,['Vandana Singh'],"Sanofi SA SNY struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson JNJ, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli ( 9-valent ) .",https://cdn.benzinga.com/files/images/story/2023/10/03/sny.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.156513,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.129704', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.636698', 'ticker_sentiment_score': '0.043427', 'ticker_sentiment_label': 'Neutral'}]"
"Medicare drug price negotiations move forward with all drugmakers participating, White House says",https://www.marketwatch.com/story/medicare-drug-price-negotiations-move-forward-with-all-drugmakers-participating-white-house-says-45b891dc,20231003T120000,['Eleanor Laise'],Novo Nordisk is latest drugmaker to challenge negotiation program in court.,https://images.mktw.net/im-861558/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.026422,Neutral,"[{'ticker': 'ABBV', 'relevance_score': '0.1789', 'ticker_sentiment_score': '-0.043857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.236972', 'ticker_sentiment_score': '-0.012794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.11983', 'ticker_sentiment_score': '-0.027305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.11983', 'ticker_sentiment_score': '-0.018592', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh; launches campaign #AcuvueSePoochho,https://www.financialexpress.com/business/brandwagon-johnson-amp-johnson-visions-acuvue-onboards-ranveer-singh-launches-campaign-acuvuesepoochho-3261578/,20231003T105700,['BrandWagon Online'],Johnson & Johnson Vision's ACUVUE onboards Ranveer Singh. launches campaign #AcuvueSePoochho The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/10/Godrej-4.png,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.400879,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.241684', 'ticker_sentiment_score': '0.367067', 'ticker_sentiment_label': 'Bullish'}]"
Sanofi clinches vaccine deal with J&J to battle E. coli,https://www.financialexpress.com/healthcare/pharma-healthcare/sanofi-clinches-vaccine-deal-with-jj-to-battle-e-coli/3261648/,20231003T102740,['Bloomberg'],"Sanofi struck a deal to help fund and sell an experimental vaccine developed by Johnson & Johnson against an invasive form of the digestive pathogen E. coli. Sanofi will pay J&J's Janssen unit $175 million upfront, as well as development and commercial milestones, the French drugmaker said in a ...",https://www.financialexpress.com/wp-content/uploads/2023/08/syring.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.03832,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.269776', 'ticker_sentiment_score': '-0.159895', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SNY', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.026922', 'ticker_sentiment_label': 'Neutral'}]"
Sanofi in agreement with Janssen to develop E. coli the vaccine candidate,https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-agreement-with-janssen-develop-e-coli-vaccine-candidate-2023-10-03/,20231003T054400,['Reuters'],"[1/2] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File Photo Acquire Licensing Rights",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/7HD6P27M3VN2FPAJVC4ZXNYOKQ.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.148454,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.401331', 'ticker_sentiment_score': '0.354898', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.964732', 'ticker_sentiment_score': '0.265263', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli,https://www.globenewswire.com/news-release/2023/10/03/2753274/0/en/Press-Release-Sanofi-announces-agreement-for-potential-first-in-class-vaccine-against-extraintestinal-pathogenic-E-coli.html,20231003T053000,['Sanofi - Aventis Groupe'],"• Extraintestinal pathogenic E. coli ( ExPEC ) is a leading bacterial cause of sepsis, causing approximately 10 million cases of invasive ExPEC disease ( IED ) annually, worldwide1,2 • Phase 3 clinical trial of vaccine candidate ongoing. Novel ExPEC vaccine expected to complement existing older ...",https://ml-eu.globenewswire.com/Resource/Download/06da731a-67a1-4258-939f-6ef0531ee3bf,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.007307,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.195905', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.282641', 'ticker_sentiment_score': '0.076525', 'ticker_sentiment_label': 'Neutral'}]"
Press Release Biocartis Group NV: Disclosure of transparency notification,https://www.globenewswire.com/news-release/2023/10/03/2753267/0/en/Press-Release-Biocartis-Group-NV-Disclosure-of-transparency-notification.html,20231003T050000,['Biocartis NV'],"PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST ...",https://ml-eu.globenewswire.com/Resource/Download/c576d4bd-cacb-49bc-a12a-5c3607f3b067,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.136347,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.03473', 'ticker_sentiment_score': '0.081086', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.428632', 'ticker_sentiment_score': '0.23394', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2158852/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,20231002T214518,['Zacks Equity Research'],"Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.",https://staticx-tuner.zacks.com/images/default_article_images/default319.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.166067,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.540358', 'ticker_sentiment_score': '0.277964', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Experts are worried about tuberculosis again,https://theweek.com/health/experts-are-worried-about-tuberculosis-again,20231002T211322,['Devika Rao'],Tuberculosis is once again causing concern The Week ...,https://cdn.mos.cms.futurecdn.net/SELv9BGJyGKCRRtmtio3oj-415-80.jpg,The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.043918,Neutral,"[{'ticker': 'FRNWF', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.058669', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.05234', 'ticker_sentiment_score': '0.076018', 'ticker_sentiment_label': 'Neutral'}]"
Drugmakers opt in to Medicare drug price negotiations - here's what happens next,https://www.cnbc.com/2023/10/02/drugmakers-agree-to-medicare-price-negotiations-whats-next.html,20231002T193402,['Annika Kim Constantino'],"The lengthy negotiation process with Medicare won't end until August 2024, with reduced prices going into effect in January 2026.",https://image.cnbcfm.com/api/v1/image/106330644-1578667127386rts2xt0x.jpg?v=1696275242&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}]",0.014398,Neutral,"[{'ticker': 'ABBV', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.183448', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.2125', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.102231', 'ticker_sentiment_score': '-0.114146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051221', 'ticker_sentiment_score': '-0.057993', 'ticker_sentiment_label': 'Neutral'}]"
Drugmakers sign on to negotiate Medicare prices under protest,https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-sign-negotiate-medicare-prices-under-protest-2023-10-02/,20231002T171200,"['Michael Erman', 'Patrick Wingrove']","U.S. President Joe Biden delivers remarks on Social Security and Medicare at the University of Tampa in Tampa, Florida, U.S. February 9, 2023. REUTERS/Jonathan Ernst/File Photo Acquire Licensing Rights",https://graphics.reuters.com/HEALTH-USA/gdvzwdbjjpw/chart.png,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.040332,Neutral,"[{'ticker': 'NVO', 'relevance_score': '0.169081', 'ticker_sentiment_score': '-0.101087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.033017', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.033017', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.033017', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Urged To Expand Access To Tuberculosis Medication - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/10/35030857/johnson-johnson-urged-to-expand-access-tuberculosis-medication,20231002T162851,['Vandana Singh'],"Global health aid agency Unitaid is advocating for expanded access to tuberculosis ( TB ) drug, bedaquiline, produced by Johnson & Johnson JNJ. The push comes as countries like South Africa, Belarus, and Ukraine grapple with high TB cases but limited access to the medication.",https://cdn.benzinga.com/files/images/story/2023/10/02/aapharma_2.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.045706,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.517168', 'ticker_sentiment_score': '-0.176073', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
J&J's  ( JNJ )  Rybrevant Combo Meets Primary Goal in NSCLC Study,https://www.zacks.com/stock/news/2158753/jjs-jnj-rybrevant-combo-meets-primary-goal-in-nsclc-study,20231002T144500,['Zacks Equity Research'],J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.,https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.194358,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.043345', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.302243', 'ticker_sentiment_score': '-0.022095', 'ticker_sentiment_label': 'Neutral'}]"
Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C.,https://www.globenewswire.com/news-release/2023/10/02/2752834/20327/en/Capital-Product-Partners-L-P-Announces-the-Appointment-of-Director-by-Capital-GP-L-L-C.html,20231002T131000,"['L.P.', 'Capital Product Partners']","ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P. ( NASDAQ: CPLP ) ( the ""Partnership"" ) today announced that Capital GP L.L.C., its general partner ( the ""General Partner"" ) , has appointed Mr. Atsunori Kozuki to act as a member of the Board of Directors of the ...",https://ml.globenewswire.com/Resource/Download/c5469a46-a926-41a4-81a9-e4048250f529,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.009386,Neutral,"[{'ticker': 'KTERF', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IPXHF', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Capital Product Partners L.P. Announces the Appointment of Director by Capital GP L.L.C. - Capital Product Partners  ( NASDAQ:CPLP ) ,https://www.benzinga.com/pressreleases/23/10/g35031145/capital-product-partners-l-p-announces-the-appointment-of-director-by-capital-gp-l-l-c,20231002T131000,['Globe Newswire'],"ATHENS, Greece, Oct. 02, 2023 ( GLOBE NEWSWIRE ) -- Capital Product Partners L.P.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.007024,Neutral,"[{'ticker': 'KTERF', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IPXHF', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
2 Exceptional Dividend Stocks to Buy in October and Hold Forever,https://www.fool.com/investing/2023/10/01/x-dividend-stocks-to-buy-in-october-and-hold-forev/,20231001T104700,['Cory Renauer'],Temporary challenges are creating bargain opportunities for investors with a long-term mindset.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749297%2Finvestor-checking-stocks-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}]",0.142856,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.405963', 'ticker_sentiment_score': '0.165592', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVS', 'relevance_score': '0.405963', 'ticker_sentiment_score': '0.210499', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.180685', 'ticker_sentiment_score': '0.044748', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.060694', 'ticker_sentiment_score': '0.089268', 'ticker_sentiment_label': 'Neutral'}]"
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?,https://www.fool.com/investing/2023/10/01/could-kenvue-become-top-dividend-stock/,20231001T100000,['Adria Cimino'],Kenvue says rewarding shareholders is an important part of its strategy.,https://media.ycharts.com/charts/06ad0f09f200a94dc3bbf022dd1eff40.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.374795,Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.728774', 'ticker_sentiment_score': '0.48695', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.089984', 'ticker_sentiment_label': 'Neutral'}]"
"StockNews.com Upgrades Johnson & Johnson  ( NYSE:JNJ )  to ""Strong-Buy""",https://www.defenseworld.net/2023/10/01/stocknews-com-upgrades-johnson-johnson-nysejnj-to-strong-buy.html,20231001T072843,['Defense World Staff'],StockNews.com Upgrades Johnson & Johnson ( NYSE:JNJ ) to ... Defense World ...,https://www.marketbeat.com/logos/johnson--johnson-logo.png?v=20221020135923,Stocknews.com,n/a,www.defenseworld.net,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.252093,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.208701', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'STT', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.208701', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.006874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.006874', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.137783', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.734323', 'ticker_sentiment_score': '0.398835', 'ticker_sentiment_label': 'Bullish'}]"
"Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role - Illumina  ( NASDAQ:ILMN ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/pressreleases/23/11/g35674541/global-precision-medicine-market-size-demonstrates-consistent-growth-with-a-cagr-of-11-12-with-nor,20231108T145000,['Globe Newswire'],"New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Precision medicine is a new approach to treating and preventing disease that considers each individual's genetic, environmental, and lifestyle differences. Giving the proper treatment to the right patient at the right time is the goal ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.145794,Neutral,"[{'ticker': 'META', 'relevance_score': '0.039353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.039353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PACB', 'relevance_score': '0.039353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ILMN', 'relevance_score': '0.194868', 'ticker_sentiment_score': '0.144939', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.039353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QGEN', 'relevance_score': '0.039353', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.115839', 'ticker_sentiment_label': 'Neutral'}]"
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/11/08/3-brilliant-artificial-intelligence-stocks-to-buy/,20231108T144500,['George Budwell'],Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.,https://media.ycharts.com/charts/01d300b996544c02ee10736173aaf87e.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.394116,Bullish,"[{'ticker': 'GEHC', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.203089', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.298817', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.267419', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GE', 'relevance_score': '0.158868', 'ticker_sentiment_score': '0.203089', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.106305', 'ticker_sentiment_score': '-0.006663', 'ticker_sentiment_label': 'Neutral'}]"
"Global Men's Personal Care Market Set to Reach USD 68.89 Billion by 2030, Fueled by Rising Awareness and Fashion Trends",https://www.benzinga.com/pressreleases/23/11/g35672962/global-mens-personal-care-market-set-to-reach-usd-68-89-billion-by-2030-fueled-by-rising-awareness,20231108T140000,['Globe Newswire'],"New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- The perception of beauty standards for men is changing. Decades-long gender stereotypes have begun to break down, and men's and women's beauty products are now being created.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.361556,Bullish,"[{'ticker': 'META', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.052699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BDRFF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KAOCF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UL', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EPC', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LRLCF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COTY', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RBGPF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.177487', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy' - AGNC Investment  ( NASDAQ:AGNC ) , Clorox  ( NYSE:CLX ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/11/35666275/jim-cramer-asks-why-the-worlds-largest-healthcare-products-company-has-an-ill-advised-st,20231108T133541,['Lisa Levin'],"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said The Clorox Company's CLX recent quarter was ""ok."" He added, ""I think that the hack is behind them. I think Linda Rendle is doing a very good job."" AGNC Investment Corp. AGNC has ""been a dog so long,"" Cramer said, ""It's just been a value trap.""",https://cdn.benzinga.com/files/images/story/2023/11/08/jim_cramer_shutter4.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.012186,Neutral,"[{'ticker': 'CSCO', 'relevance_score': '0.539306', 'ticker_sentiment_score': '0.061521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AGNC', 'relevance_score': '0.539306', 'ticker_sentiment_score': '0.051247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTR', 'relevance_score': '0.539306', 'ticker_sentiment_score': '-0.071567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.539306', 'ticker_sentiment_score': '-0.145642', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.539306', 'ticker_sentiment_score': '-0.064939', 'ticker_sentiment_label': 'Neutral'}]"
Grab these 2 funds with rich 11%-12% yields while you can,https://www.marketwatch.com/story/grab-these-2-funds-with-rich-11-12-yields-while-you-can-f2856fb2,20231108T121800,['Michael Brush'],"If you invest for income, consider taking advantage of these unusual opportunities.",https://images.mktw.net/im-879591/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.166559,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.232625', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HESG', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.208956', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.060686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.13459', 'ticker_sentiment_score': '0.166414', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.219686', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
NANOBIOTIX Announces Closing of Global Offering,https://www.benzinga.com/pressreleases/23/11/g35657744/nanobiotix-announces-closing-of-global-offering,20231107T210100,['Globe Newswire'],"PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.999174'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.122071,Neutral,"[{'ticker': 'NBTX', 'relevance_score': '0.197951', 'ticker_sentiment_score': '0.044418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.022222', 'ticker_sentiment_score': '0.056509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.022222', 'ticker_sentiment_score': '0.046698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.044427', 'ticker_sentiment_score': '0.035549', 'ticker_sentiment_label': 'Neutral'}]"
Inside the Dividend Monarchs ETF  ( KNGS ) ,https://www.zacks.com/stock/news/2180335/inside-the-dividend-monarchs-etf-kngs,20231107T190000,['Sanghamitra Saha'],The newly-launched KNGS ETF holds 30+ stocks. These stocks have been in a position to consistently raise their dividends over the last 50 years.,https://staticx-tuner.zacks.com/images/default_article_images/default77.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999939'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.212486,Somewhat-Bullish,"[{'ticker': 'PEP', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.005071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.005071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.005071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.005071', 'ticker_sentiment_label': 'Neutral'}]"
Q1 2023/24 - Lower revenue in a challenging market,https://www.globenewswire.com/news-release/2023/11/07/2775449/0/en/Q1-2023-24-Lower-revenue-in-a-challenging-market.html,20231107T190000,['Chemometec A/S'],ANNOUNCEMENT NO. ...,https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.576289'}]",-0.033238,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.029951', 'ticker_sentiment_score': '0.037699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.029951', 'ticker_sentiment_score': '0.037699', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029951', 'ticker_sentiment_score': '0.037699', 'ticker_sentiment_label': 'Neutral'}]"
Genmab Announces Financial Results for the First Nine Months of 2023,https://www.globenewswire.com/news-release/2023/11/07/2775338/0/en/Genmab-Announces-Financial-Results-for-the-First-Nine-Months-of-2023.html,20231107T160100,['Genmab A/S'],"November 7, 2023 Copenhagen, Denmark. Interim Report for the First Nine Months Ended September ...",https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.614606'}, {'topic': 'Earnings', 'relevance_score': '0.266143'}, {'topic': 'Economy - Macro', 'relevance_score': '0.310843'}]",0.129352,Neutral,"[{'ticker': 'NVS', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.143629', 'ticker_sentiment_score': '0.083262', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.065655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GMAB', 'relevance_score': '0.412861', 'ticker_sentiment_score': '0.117511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.072108', 'ticker_sentiment_score': '0.073576', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson to submit application to start trials for surgical robot,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-submit-application-start-trials-its-robotic-surgical-system-2023-11-07/,20231107T131200,['Reuters'],Johnson & Johnson to submit application to start trials for its robotic surgical system ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/4L7SJNLFZJJ65BIEBCLWLVUH2M.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.126574,Neutral,"[{'ticker': 'MDT', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade,https://www.fool.com/investing/2023/11/07/2-magnificent-dividend-stocks-trading-near-52-week/,20231107T103700,['Cory Renauer'],Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753925%2Fcouple-looking-at-stocks-on-tablet-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.200775,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.204955', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MO', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.20114', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.223045', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Anti-Infective Drugs Market to Hit USD 177.9 billion by 2031 | Transparency Market Research Inc.,https://www.benzinga.com/pressreleases/23/11/g35637643/anti-infective-drugs-market-to-hit-usd-177-9-billion-by-2031-transparency-market-research-inc,20231107T103000,['Globe Newswire'],"Wilmington, Delaware, United States, Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anti-infective drugs market is projected to flourish at a CAGR of 4.0% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 117.9 billion is anticipated for ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.195618,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPMF', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEVA', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.212463', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.043658', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.043658', 'ticker_sentiment_score': '-0.109878', 'ticker_sentiment_label': 'Neutral'}]"
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/11/07/2-monster-stocks-to-buy-without-any-hesitation/,20231107T100500,['Josh Kohn-Lindquist'],"Down 33% and 44%, these two stocks look too good to pass up today.",https://media.ycharts.com/charts/fd056e541104c424277123a2aae7f156.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.082347,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.429752', 'ticker_sentiment_score': '0.131906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.240149', 'ticker_sentiment_score': '0.123234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.034831', 'ticker_sentiment_score': '-0.193184', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.034831', 'ticker_sentiment_score': '-0.076883', 'ticker_sentiment_label': 'Neutral'}]"
"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... - PR Newswire",https://www.prnewswire.com/news-releases/mobile-health-solutions-market-to-grow-at-a-usd-256-69-billion-from-2022-to-2027--abbott-laboratories-airstrip-technologies-inc-apple-inc-and-more-among-the-key-companies-in-the-market---technavio-301978707.html,20231107T011500,[],"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.324869,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MASI', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.275034', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ORCL', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMRNF', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDRX', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.143994', 'ticker_sentiment_label': 'Neutral'}]"
"The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman - and Martin Shkreli",https://www.marketwatch.com/story/the-doctor-lowering-drug-prices-for-1-million-patients-with-help-from-mark-cuban-sam-altman-and-martin-shkreli-5e72d77a,20231106T203200,['Eleanor Laise'],Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades-the kind of drugs that should be cheap.,https://images.mktw.net/im-871045?width=700&height=393,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.066744,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.055848', 'ticker_sentiment_score': '-0.013012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.088489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.024774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.088489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHRS', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.007658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.041901', 'ticker_sentiment_score': '0.007958', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.007658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.007658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.027941', 'ticker_sentiment_score': '0.024774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.027941', 'ticker_sentiment_score': '-0.042172', 'ticker_sentiment_label': 'Neutral'}]"
Eli Lilly chief scientific officer 'extremely optimistic' that major new Alzheimer's breakthrough is coming,https://www.marketwatch.com/story/eli-lilly-chief-scientific-officer-extremely-optimistic-that-major-new-alzheimers-breakthrough-is-coming-79003fcc,20231106T160500,['Eleanor Laise'],"Dr. Daniel Skovronsky believes a big leap in Alzheimer's disease treatment may be just around the corner-and that an overlooked class of medicines could become the GLP-1 drugs of the future. If he's right, Eli Lilly & Co.'s LLY, remarkable winning streak won't fizzle any time soon.",https://images.mktw.net/im-857606/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.125979,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.365524', 'ticker_sentiment_score': '0.148178', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.075754', 'ticker_sentiment_score': '0.013501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.113418', 'ticker_sentiment_score': '0.152012', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.075754', 'ticker_sentiment_score': '0.013501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075754', 'ticker_sentiment_score': '0.154848', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.prnewswire.com/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978609.html,20231106T160000,['Kohler Co.'],Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...,https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.472755,Bullish,"[{'ticker': 'IR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.020275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSIX', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.268035', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.prnewswire.com/in/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978615.html,20231106T160000,['Kohler Co.'],Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...,https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.472755,Bullish,"[{'ticker': 'IR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.020275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSIX', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.268035', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",https://www.newswire.ca/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-871976866.html,20231106T160000,['Kohler Co.'],Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... Canada ...,https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook,Canada Newswire,n/a,www.newswire.ca,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.472755,Bullish,"[{'ticker': 'IR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.020275', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.035397', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PSIX', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.268035', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Mind-altering ketamine becomes new pain treatment, despite little research or regulation",https://apnews.com/article/ketamine-pain-drugs-psychedelic-fda-2c67eeac1932962a7b0affc07d24c09a,20231106T135700,['MATTHEW PERRONE'],"WASHINGTON ( AP ) - As U.S. doctors scale back their use of , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a .",https://dims.apnews.com/dims4/default/4d1405a/2147483647/strip/true/crop/5138x3422+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fcb%2Fcc%2F05d9f9c9a82aa131c2ce9b7f669f%2F862a7fd642e64538b8d642dc596641cc,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",-0.190668,Somewhat-Bearish,"[{'ticker': 'HHH', 'relevance_score': '0.028695', 'ticker_sentiment_score': '0.156844', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.028695', 'ticker_sentiment_score': '-0.163383', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Anavex Life Sciences Appoints Senior VP of Regulatory Affairs,https://www.globenewswire.com/news-release/2023/11/06/2774022/29248/en/Anavex-Life-Sciences-Appoints-Senior-VP-of-Regulatory-Affairs.html,20231106T130000,['Anavex Life Sciences Corp.'],"NEW YORK, Nov. 06, 2023 ( GLOBE NEWSWIRE ) -- Anavex Life Sciences Corp. ( ""Anavex"" or the ""Company"" ) ( Nasdaq: AVXL ) , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including ...",https://ml.globenewswire.com/Resource/Download/1b0f858f-4f7f-4f50-b691-a25307283fb5,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.151385,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.048786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVXL', 'relevance_score': '0.22616', 'ticker_sentiment_score': '-0.001786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04583', 'ticker_sentiment_score': '0.101487', 'ticker_sentiment_label': 'Neutral'}]"
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35611321/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue,20231105T213127,['Globe Newswire'],"NEW YORK, Nov. 05, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.021762,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.691995', 'ticker_sentiment_score': '0.011422', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.021477', 'ticker_sentiment_label': 'Neutral'}]"
"Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest - CVS Health  ( NYSE:CVS ) , SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , Johnson & Johnson  ( NYSE:JNJ ) , Walgreens Boots Alliance  ( NASDAQ:WBA ) ",https://www.benzinga.com/news/23/11/35610842/pharmacy-workers-strike-at-cvs-and-walgreens-echoing-wider-pharma-sector-unrest,20231105T204848,['Bibhu Pattnaik'],"In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation CVS and Walgreens Boots Alliance, Inc. WBA raised their voices by calling out sick or walking out entirely last week.",https://cdn.benzinga.com/files/images/story/2023/11/05/shutterstock_1049642744.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.08705,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.343755', 'ticker_sentiment_score': '0.16233', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.14131', 'ticker_sentiment_score': '0.067842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RADCQ', 'relevance_score': '0.070935', 'ticker_sentiment_score': '-0.096496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.14131', 'ticker_sentiment_score': '-0.093063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.14131', 'ticker_sentiment_score': '-0.207786', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NYT', 'relevance_score': '0.14131', 'ticker_sentiment_score': '-0.206552', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.14131', 'ticker_sentiment_score': '-0.093063', 'ticker_sentiment_label': 'Neutral'}]"
"KVUE Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of Securities Fraud Class Action Lawsuit - Kenvue  ( NYSE:KVUE ) ",https://www.benzinga.com/pressreleases/23/11/g35606416/kvue-class-action-reminder-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvue-investors-of-se,20231104T144600,['Globe Newswire'],"RADNOR, Pa., Nov. 04, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( ""Kenvue"" ) KVUE. ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.096899,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.526003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.129961', 'ticker_sentiment_label': 'Neutral'}]"
KENVUE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/pressreleases/23/11/g35605845/kenvue-shareholder-action-reminder-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-e,20231104T120000,['Globe Newswire'],"If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the ""Registration Statement"" ) issued in connection with the Company's May 2023 initial public offering ( the ""IPO"" or ""Offering"" ) and ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.1474,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.623692', 'ticker_sentiment_score': '0.025572', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.09307', 'ticker_sentiment_label': 'Neutral'}]"
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/11/04/want-passive-income-top-dividend-stocks-to-buy/,20231104T093000,['Adria Cimino'],Dividend stocks can cushion your portfolio in times of market trouble.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753700%2Fgettyimages-1319763362.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.947132'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.366922,Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.367606', 'ticker_sentiment_score': '0.354643', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.047997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.104043', 'ticker_sentiment_label': 'Neutral'}]"
KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire,https://www.prnewswire.com/news-releases/kenvue-shareholder-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301976714.html,20231104T004500,[],KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.150018,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.600121', 'ticker_sentiment_score': '0.021496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.093005', 'ticker_sentiment_label': 'Neutral'}]"
Weekly Roundup,https://aap.thestreet.com/story/16137219/1/weekly-roundup.html,20231103T222900,[],"All four major market indexes climbed higher in the first days of November, putting each except for the Russell 2000 in positive territory quarter-to date. A less-hawkish-than-expected Fed, retreating Treasury yields and slower job growth spurred the buying.",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/391cf3d8-7a8d-11ee-b0ee-d18e297040ba.png,The Street,GoogleRSS,aap.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.99489'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.189331,Somewhat-Bullish,"[{'ticker': 'AMAT', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.032106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CELH', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.098697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.003869', 'ticker_sentiment_score': '-0.017189', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DE', 'relevance_score': '0.02321', 'ticker_sentiment_score': '0.084109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDLZ', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.098697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.02321', 'ticker_sentiment_score': '0.112497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.034809', 'ticker_sentiment_score': '0.096219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRIN', 'relevance_score': '0.015474', 'ticker_sentiment_score': '0.072102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.025532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.093507', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.154498', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXON', 'relevance_score': '0.011606', 'ticker_sentiment_score': '0.110566', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YERBF', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.098697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'URI', 'relevance_score': '0.02321', 'ticker_sentiment_score': '0.045618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.02321', 'ticker_sentiment_score': '0.092246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.070906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.027077', 'ticker_sentiment_score': '0.12651', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.003869', 'ticker_sentiment_score': '-0.019235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.015474', 'ticker_sentiment_score': '0.086543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.096158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GFS', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.025532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.042537', 'ticker_sentiment_score': '0.109398', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OLED', 'relevance_score': '0.015474', 'ticker_sentiment_score': '-0.020098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UTZ', 'relevance_score': '0.015474', 'ticker_sentiment_score': '0.076312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.030943', 'ticker_sentiment_score': '0.097072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.015474', 'ticker_sentiment_score': '0.10054', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.003869', 'ticker_sentiment_score': '-0.017189', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSI', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.198468', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.030943', 'ticker_sentiment_score': '0.099277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'USEG', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.039346', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMT', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.120363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICNB', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.178317', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VMC', 'relevance_score': '0.011606', 'ticker_sentiment_score': '0.02438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.02321', 'ticker_sentiment_score': '0.101726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNHI', 'relevance_score': '0.015474', 'ticker_sentiment_score': '0.046086', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.011606', 'ticker_sentiment_score': '0.023035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLESY', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.069533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IPAR', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.025532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.019342', 'ticker_sentiment_score': '0.090796', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.042537', 'ticker_sentiment_score': '0.102618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYNA', 'relevance_score': '0.007738', 'ticker_sentiment_score': '0.025532', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.003869', 'ticker_sentiment_score': '0.10621', 'ticker_sentiment_label': 'Neutral'}]"
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc---kvue-301977470.html,20231103T203600,['Pomerantz LLP'],"NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( ""Kenvue"" or the ""Company"" ) ( NYSE: KVUE ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}]",0.053268,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.725935', 'ticker_sentiment_score': '0.070022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.023342', 'ticker_sentiment_label': 'Neutral'}]"
"Medela Announces Transition of Wound Care Business, Creating a New Company Dedicated to Wound Therapy Solutions",https://www.benzinga.com/pressreleases/23/11/g35597861/medela-announces-transition-of-wound-care-business-creating-a-new-company-dedicated-to-wound-thera,20231103T174242,['Globe Newswire'],"Baar, Switzerland, Nov. 03, 2023 ( GLOBE NEWSWIRE ) -- Medela, a global healthcare company known for being the most trusted breastfeeding brand in North America*, announced it will transition its wound care business into a separate global company.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Mergers,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.301002,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.140718', 'ticker_sentiment_label': 'Neutral'}]"
Council Post: What Startups Can Learn From Titans About Treasury Management,https://www.forbes.com/sites/forbesbusinesscouncil/2023/11/03/what-startups-can-learn-from-titans-about-treasury-management/,20231103T143000,['Will Fan'],What Startups Can Learn From Titans About Treasury Management Forbes ...,https://imageio.forbes.com/specials-images/imageserve/646f6244f3faa9c0f6569957/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds,Forbes,n/a,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.33964,Somewhat-Bullish,"[{'ticker': 'BRK-A', 'relevance_score': '0.104835', 'ticker_sentiment_score': '0.314809', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.035035', 'ticker_sentiment_score': '0.067637', 'ticker_sentiment_label': 'Neutral'}]"
This Stock Just Dropped By 15%: Is It a Buy?,https://www.fool.com/investing/2023/11/03/this-stock-just-dropped-by-15-is-it-a-buy/,20231103T140700,['Prosper Junior Bakiny'],Now could be a great opportunity to buy low.,https://media.ycharts.com/charts/f17aae7f0e5b860659a29816cf8131bc.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.159727,Somewhat-Bullish,"[{'ticker': 'PFE', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.047', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.461699', 'ticker_sentiment_score': '0.192137', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2177963/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,20231103T130010,['Zacks Equity Research'],"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default355.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.237374,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.478494', 'ticker_sentiment_score': '0.159977', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Top-Ranked PIMCO Mutual Funds for 2023 & Beyond,https://www.zacks.com/stock/news/2177867/3-top-ranked-pimco-mutual-funds-for-2023-beyond,20231103T105300,['Zacks Equity Research'],"Invest in PIMCO mutual funds like PMJPX, PKAAX and PQIPX that have given positive returns amid uncertain market conditions and are expected to perform well in the future.",https://staticx-tuner.zacks.com/images/articles/main/f1/51384.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999922'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}]",0.272157,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.050941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDS', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.050941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.05394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.113866', 'ticker_sentiment_score': '0.058594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.05394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ANF', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.050941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCC', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.050941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.057079', 'ticker_sentiment_score': '0.050941', 'ticker_sentiment_label': 'Neutral'}]"
3 Healthcare Stocks to Buy Hand Over Fist in November,https://www.fool.com/investing/2023/11/03/3-health-stocks-to-buy-hand-over-fist-in-november/,20231103T090000,['Adria Cimino'],Get these stocks while they're cheap.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753459%2Fgettyimages-1027653456.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.9996'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.302997,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.482054', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.162073', 'ticker_sentiment_score': '0.183261', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301976551.html,20231103T073500,[],"Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.041186,Neutral,"[{'ticker': 'SNN', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVY', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZLGF', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPBY', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ORGO', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNVVF', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.082775', 'ticker_sentiment_label': 'Neutral'}]"
Montana GOP Senate candidate would be in the top 10 richest lawmakers - and his investments are sure to irk some conservatives,https://www.businessinsider.com/tim-sheehy-montana-wealthy-republican-climate-change-china-investments-2023-11,20231102T203500,['Bryan Metzger'],"GOP hopeful Sheehy is super rich, invested in things conservatives hate - Business Insider ...",,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}]",0.149242,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.049977', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.058472', 'ticker_sentiment_score': '-0.167', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAER', 'relevance_score': '0.058472', 'ticker_sentiment_score': '-0.080982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RPRX', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.041013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCTZF', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.100988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058472', 'ticker_sentiment_score': '0.041013', 'ticker_sentiment_label': 'Neutral'}]"
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/11/02/2772866/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2023-Financial-Results.html,20231102T201500,"['Cidara Therapeutics', 'Inc.']","SAN DIEGO, Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- Cidara Therapeutics, Inc. ( Nasdaq: CDTX ) , a biotechnology company focused on developing targeted therapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the ...",https://ml.globenewswire.com/Resource/Download/97036182-e328-4e3f-a1ef-6d4a151e97cb,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.972756'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998663'}]",0.159258,Somewhat-Bullish,"[{'ticker': 'CDTX', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.171614', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.024546', 'ticker_sentiment_score': '0.061222', 'ticker_sentiment_label': 'Neutral'}]"
"EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience' - Target  ( NYSE:TGT ) , Kimberly-Clark  ( NYSE:KMB ) , Coca-Cola  ( NYSE:KO ) , Listed Funds Trust Roundhill Cannabis ETF  ( BATS:WEED ) ",https://www.benzinga.com/trading-ideas/dividends/23/11/35572980/exclusive-roundhill-launches-dividend-kings-etf-with-the-gold-standard-of-dividend-grower,20231102T182538,['Chris Katje'],"The company behind pure-play ETFs that cover sectors such as cannabis stocks, the metaverse, sports betting and meme stocks is back with a new fund that covers a popular investment strategy. What Happened: Roundhill Investments launched the Roundhill S&P Dividend Monarchs ETF KNGS on Thursday.","https://cdn.benzinga.com/files/images/story/2023/Chess,Gold,Leadership,On,The,Chessboard.,How,To,Trade,In.jpeg?width=1200&height=800&fit=crop",Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.175356,Somewhat-Bullish,"[{'ticker': 'TGT', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMB', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.12645', 'ticker_sentiment_score': '-0.038107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWKH', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12645', 'ticker_sentiment_score': '-0.038107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRT', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEG', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SON', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.12645', 'ticker_sentiment_score': '-0.038107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.12645', 'ticker_sentiment_score': '-0.038107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKH', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
JNJ: 3 Pharma Stocks to Capitalize on With Potential Upside,https://stocknews.com/news/jnj-bmy-gsk-me-3-pharma-stocks-to-capitalize-on-with-potential-upside/,20231102T180515,['StockNews.com Staff'],"The pharmaceutical sector is poised for robust growth, propelled by the rapidly expanding market for medications and vaccines. Moreover, the consistent demand for its products upholds the industry's resilience, rendering it less vulnerable to economic fluctuations.",https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1110645284.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999922'}, {'topic': 'Earnings', 'relevance_score': '0.999956'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.281467,Somewhat-Bullish,"[{'ticker': 'ME', 'relevance_score': '0.033328', 'ticker_sentiment_score': '0.157804', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GSK', 'relevance_score': '0.23008', 'ticker_sentiment_score': '0.234432', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.165484', 'ticker_sentiment_score': '0.149924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.23008', 'ticker_sentiment_score': '0.168599', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Novo Nordisk, Lilly see insatiable demand for weight-loss drugs",https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-lilly-see-insatiable-demand-weight-loss-drugs-2023-11-02/,20231102T171500,"['Maggie Fick', 'Bhanvi Satija']",Nov 2 ( Reuters ) - Novo Nordisk ( NOVOb.CO ) and Eli Lilly ( LLY.N ) both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their availability.,https://s3.amazonaws.com/arc-authors/reuters/24e53264-190b-4097-835a-edeca236a9f4.png,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.218052,Somewhat-Bullish,"[{'ticker': 'IVZ', 'relevance_score': '0.063425', 'ticker_sentiment_score': '-0.095051', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.188683', 'ticker_sentiment_score': '0.240477', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063425', 'ticker_sentiment_score': '-0.07403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.150143', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/11/35569909/looking-into-johnson-johnsons-recent-short-interest,20231102T164522,['Benzinga Insights'],"Johnson & Johnson's JNJ short percent of float has fallen 12.16% since its last report. The company recently reported that it has 15.68 million shares sold short, which is 0.65% of all regular shares that are available for trading.",https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.237013,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.081322', 'ticker_sentiment_label': 'Neutral'}]"
Why Nanobiotix  ( NBTX )  Stock Is Plunging Thursday - Nanobiotix  ( NASDAQ:NBTX ) ,https://www.benzinga.com/news/23/11/35566629/why-nanobiotix-nbtx-stock-is-plunging-thursday,20231102T150640,['Henry Khederian'],"Nanobiotix SA - ADR NBTX shares are trading lower by 16.4% to $5.14 Thursday morning after the company priced its global follow-on offering. The offering includes 3,106,907 ADSs in the U.S. at $5.36 per ADS and 2,492,223 Ordinary Shares in Europe at €5.07 per share.",https://cdn.benzinga.com/files/images/story/2023/11/02/vaccine-4892048.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.059099,Neutral,"[{'ticker': 'NBTX', 'relevance_score': '0.693563', 'ticker_sentiment_score': '0.225086', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.266828', 'ticker_sentiment_score': '-0.028581', 'ticker_sentiment_label': 'Neutral'}]"
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.benzinga.com/pressreleases/23/11/g35566174/nanobiotix-announces-pricing-of-a-capital-increase-raising-total-gross-proceeds-of-55m,20231102T144949,['Globe Newswire'],"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.128579,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.012294', 'ticker_sentiment_score': '0.056659', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCAP', 'relevance_score': '0.012294', 'ticker_sentiment_score': '0.08937', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBTX', 'relevance_score': '0.122456', 'ticker_sentiment_score': '0.059398', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.012294', 'ticker_sentiment_score': '0.062192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.024584', 'ticker_sentiment_score': '0.098302', 'ticker_sentiment_label': 'Neutral'}]"
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.globenewswire.com/news-release/2023/11/02/2772565/0/en/NANOBIOTIX-Announces-Pricing-of-a-Capital-Increase-Raising-Total-Gross-Proceeds-of-55M.html,20231102T144900,['Nanobiotix S.A.'],"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.137906,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.0123', 'ticker_sentiment_score': '0.060057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCAP', 'relevance_score': '0.0123', 'ticker_sentiment_score': '0.055877', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBTX', 'relevance_score': '0.122518', 'ticker_sentiment_score': '0.062999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.0123', 'ticker_sentiment_score': '0.067647', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.024597', 'ticker_sentiment_score': '0.114566', 'ticker_sentiment_label': 'Neutral'}]"
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M,https://www.globenewswire.com/news-release/2023/11/02/2772563/0/en/NANOBIOTIX-Announces-Pricing-of-a-Capital-Increase-Raising-Total-Gross-Proceeds-of-55M.html,20231102T144900,['Nanobiotix S.A.'],"PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.144764,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.011513', 'ticker_sentiment_score': '0.059663', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCAP', 'relevance_score': '0.011513', 'ticker_sentiment_score': '0.05552', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBTX', 'relevance_score': '0.114737', 'ticker_sentiment_score': '0.060016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.011513', 'ticker_sentiment_score': '0.067248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.023024', 'ticker_sentiment_score': '0.11363', 'ticker_sentiment_label': 'Neutral'}]"
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant,https://www.globenewswire.com/news-release/2023/11/01/2771818/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html,20231101T223200,['Nanobiotix S.A.'],"PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.162967,Somewhat-Bullish,"[{'ticker': 'STT', 'relevance_score': '0.011762', 'ticker_sentiment_score': '0.048841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCAP', 'relevance_score': '0.011762', 'ticker_sentiment_score': '0.05952', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBTX', 'relevance_score': '0.128822', 'ticker_sentiment_score': '0.052608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.011762', 'ticker_sentiment_score': '0.06556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.023521', 'ticker_sentiment_score': '0.102479', 'ticker_sentiment_label': 'Neutral'}]"
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant,https://www.globenewswire.com/news-release/2023/11/01/2771817/0/en/NANOBIOTIX-Announces-Launch-of-Global-Follow-On-Offering-and-a-Concurrent-Private-Placement-Along-with-the-Removal-of-the-EIB-Cash-Covenant.html,20231101T223000,['Nanobiotix S.A.'],"PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - ""Nanobiotix"" or the ""Company"" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.158462,Somewhat-Bullish,"[{'ticker': 'STT', 'relevance_score': '0.012624', 'ticker_sentiment_score': '0.049201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCAP', 'relevance_score': '0.012624', 'ticker_sentiment_score': '0.059939', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBTX', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.057426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.012624', 'ticker_sentiment_score': '0.065986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.025245', 'ticker_sentiment_score': '0.103418', 'ticker_sentiment_label': 'Neutral'}]"
Prostate Cancer Minimally Invasive Surgery Market Size is Envisioned to Grow at a CAGR of 3.6% and reach USD 3.9 billion by 2031|Report by TMR,https://www.benzinga.com/pressreleases/23/11/g35543727/prostate-cancer-minimally-invasive-surgery-market-size-is-envisioned-to-grow-at-a-cagr-of-3-6-and-,20231101T170000,['Globe Newswire'],"Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. The global prostate cancer minimally invasive surgery market stood at US$ 2.9 billion in 2022 and is projected to reach US$ 3.9 billion in 2031.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.074333,Neutral,"[{'ticker': 'ISRG', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.254161', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BDX', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFX', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Sanitary Napkin Market to hit USD 41 billion by 2031, says Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/11/g35539142/sanitary-napkin-market-to-hit-usd-41-billion-by-2031-says-transparency-market-research-inc,20231101T143000,['Globe Newswire'],"Wilmington, Delaware, United States, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc- The global sanitary napkin market was estimated to have acquired US$ 24.5 billion in 2021. It is anticipated to register a 5.0% CAGR from 2022 to 2031 and by 2031, the market is likely to ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.386125,Bullish,"[{'ticker': 'HEGIF', 'relevance_score': '0.046452', 'ticker_sentiment_score': '-0.145419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EPC', 'relevance_score': '0.046452', 'ticker_sentiment_score': '-0.145419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMB', 'relevance_score': '0.046452', 'ticker_sentiment_score': '-0.145419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.046452', 'ticker_sentiment_score': '0.101757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.046452', 'ticker_sentiment_score': '0.187375', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Dividend Kings Whose Growth Streaks Could Break Before 2030,https://www.fool.com/investing/2023/11/01/3-dividend-kings-whose-growth-streaks-could-break/,20231101T141200,['David Jagielski'],"Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.",https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}]",0.031596,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.090816', 'ticker_sentiment_score': '-0.011616', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MO', 'relevance_score': '0.224487', 'ticker_sentiment_score': '0.215834', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.267804', 'ticker_sentiment_score': '0.028821', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development Board,https://www.prnewswire.com/apac/news-releases/johnson--johnson-innovation-launches-singapore-quickfire-challenge-with-the-singapore-economic-development-board-301974279.html,20231101T140500,['Johnson & Johnson Innovation LLC'],Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development ... PR ...,https://mma.prnewswire.com/media/2219093/Johnson_Johnson_Innovation_JLABS_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}]",0.40951,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.539522', 'ticker_sentiment_score': '0.489524', 'ticker_sentiment_label': 'Bullish'}]"
The Mullings Group Acquires M. J. Moore & Associates and Names Michael Moore Partner,https://www.prnewswire.com/news-releases/the-mullings-group-acquires-m-j-moore--associates-and-names-michael-moore-partner-301974041.html,20231101T130000,['The Mullings Group'],"DELRAY BEACH, Fla., Nov. 1, 2023 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M.",https://mma.prnewswire.com/media/2262635/The_Mullings_Group___Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.278049,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.170157', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.170157', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?,https://www.fool.com/investing/2023/11/01/can-kenvue-be-a-reliable-dividend-stock-to-hold-fo/,20231101T114400,['David Jagielski'],"Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?",https://g.foolcdn.com/editorial/images/752766/a-person-counting-money-in-their-living-room.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.193505,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.818793', 'ticker_sentiment_score': '0.315277', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.261818', 'ticker_sentiment_score': '0.026237', 'ticker_sentiment_label': 'Neutral'}]"
Acquisition of Industrial Vision Systems Ltd and Issue of Equity,https://www.globenewswire.com/news-release/2023/11/01/2770854/0/en/Acquisition-of-Industrial-Vision-Systems-Ltd-and-Issue-of-Equity.html,20231101T090000,['Oxford Metrics'],1 November ...,,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.465724,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.02799', 'ticker_sentiment_score': '0.243977', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LDNXF', 'relevance_score': '0.02799', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
